000182296612-312024Q2false10033.3333.33xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesutr:MWsmr:employeexbrli:puresmr:daysmr:plaintiffsmr:lawsuit00018229662024-01-012024-06-300001822966us-gaap:CommonClassAMember2024-01-012024-06-300001822966us-gaap:WarrantMember2024-01-012024-06-300001822966us-gaap:CommonClassAMember2024-08-050001822966us-gaap:CommonClassBMember2024-08-0500018229662024-06-3000018229662023-12-310001822966us-gaap:CommonClassAMember2023-12-310001822966us-gaap:CommonClassAMember2024-06-300001822966us-gaap:CommonClassBMember2024-06-300001822966us-gaap:CommonClassBMember2023-12-3100018229662024-04-012024-06-3000018229662023-04-012023-06-3000018229662023-01-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-03-310001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-03-310001822966us-gaap:AdditionalPaidInCapitalMember2024-03-310001822966us-gaap:RetainedEarningsMember2024-03-310001822966us-gaap:NoncontrollingInterestMember2024-03-3100018229662024-03-310001822966us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-04-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-04-012024-06-300001822966us-gaap:NoncontrollingInterestMember2024-04-012024-06-300001822966us-gaap:RetainedEarningsMember2024-04-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-06-300001822966us-gaap:AdditionalPaidInCapitalMember2024-06-300001822966us-gaap:RetainedEarningsMember2024-06-300001822966us-gaap:NoncontrollingInterestMember2024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-12-310001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-12-310001822966us-gaap:AdditionalPaidInCapitalMember2023-12-310001822966us-gaap:RetainedEarningsMember2023-12-310001822966us-gaap:NoncontrollingInterestMember2023-12-310001822966us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-01-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-01-012024-06-300001822966us-gaap:NoncontrollingInterestMember2024-01-012024-06-300001822966us-gaap:RetainedEarningsMember2024-01-012024-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-03-310001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-03-310001822966us-gaap:AdditionalPaidInCapitalMember2023-03-310001822966us-gaap:RetainedEarningsMember2023-03-310001822966us-gaap:NoncontrollingInterestMember2023-03-3100018229662023-03-310001822966us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-04-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-04-012023-06-300001822966us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001822966us-gaap:RetainedEarningsMember2023-04-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-300001822966us-gaap:AdditionalPaidInCapitalMember2023-06-300001822966us-gaap:RetainedEarningsMember2023-06-300001822966us-gaap:NoncontrollingInterestMember2023-06-3000018229662023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310001822966us-gaap:AdditionalPaidInCapitalMember2022-12-310001822966us-gaap:RetainedEarningsMember2022-12-310001822966us-gaap:NoncontrollingInterestMember2022-12-3100018229662022-12-310001822966us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-06-300001822966us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-01-012023-06-300001822966us-gaap:NoncontrollingInterestMember2023-01-012023-06-300001822966us-gaap:RetainedEarningsMember2023-01-012023-06-3000018229662024-01-052024-01-0500018229662024-01-050001822966srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2023-01-012023-06-300001822966us-gaap:GovernmentMembersmr:UnitedStateTradeAndDevelopmentAgencyMember2024-04-012024-06-300001822966us-gaap:GovernmentMembersmr:UnitedStateTradeAndDevelopmentAgencyMember2023-04-012023-06-300001822966us-gaap:GovernmentMembersmr:UnitedStateTradeAndDevelopmentAgencyMember2024-01-012024-06-300001822966us-gaap:GovernmentMembersmr:UnitedStateTradeAndDevelopmentAgencyMember2023-01-012023-06-300001822966smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember2024-04-012024-06-300001822966smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember2024-01-012024-06-300001822966smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember2023-04-012023-06-300001822966smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember2023-01-012023-06-300001822966us-gaap:GovernmentMembersmr:CFPPLLCMember2024-04-012024-06-300001822966us-gaap:GovernmentMembersmr:CFPPLLCMember2023-04-012023-06-300001822966us-gaap:GovernmentMembersmr:CFPPLLCMember2024-01-012024-06-300001822966us-gaap:GovernmentMembersmr:CFPPLLCMember2023-01-012023-06-300001822966us-gaap:CommonClassAMember2024-03-310001822966us-gaap:CommonClassAMember2023-03-310001822966us-gaap:CommonClassAMember2022-12-310001822966us-gaap:CommonClassAMember2024-04-012024-06-300001822966us-gaap:CommonClassAMember2023-04-012023-06-300001822966us-gaap:CommonClassAMember2023-01-012023-06-300001822966us-gaap:CommonClassAMember2023-06-300001822966us-gaap:CommonClassBMember2024-03-310001822966us-gaap:CommonClassBMember2023-03-310001822966us-gaap:CommonClassBMember2022-12-310001822966us-gaap:CommonClassBMember2024-04-012024-06-300001822966us-gaap:CommonClassBMember2023-04-012023-06-300001822966us-gaap:CommonClassBMember2024-01-012024-06-300001822966us-gaap:CommonClassBMember2023-01-012023-06-300001822966us-gaap:CommonClassBMember2023-06-300001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2024-03-310001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2023-03-310001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2023-12-310001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2022-12-310001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2024-06-300001822966smr:NuScaleCorpMemberus-gaap:CommonClassAMember2023-06-300001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2024-03-310001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2023-03-310001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2023-12-310001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2022-12-310001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2024-06-300001822966smr:NuScaleLLCMemberus-gaap:CommonClassBMember2023-06-300001822966smr:ClassBCommonSharesMember2024-04-012024-06-300001822966smr:ClassBCommonSharesMember2023-04-012023-06-300001822966smr:ClassBCommonSharesMember2024-01-012024-06-300001822966smr:ClassBCommonSharesMember2023-01-012023-06-300001822966us-gaap:StockOptionMember2024-04-012024-06-300001822966us-gaap:StockOptionMember2023-04-012023-06-300001822966us-gaap:StockOptionMember2024-01-012024-06-300001822966us-gaap:StockOptionMember2023-01-012023-06-300001822966us-gaap:WarrantMember2024-04-012024-06-300001822966us-gaap:WarrantMember2023-04-012023-06-300001822966us-gaap:WarrantMember2024-01-012024-06-300001822966us-gaap:WarrantMember2023-01-012023-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001822966us-gaap:CommonClassAMembersmr:ATMProgramMember2024-04-012024-06-300001822966us-gaap:CommonClassAMembersmr:ATMProgramMember2024-01-012024-06-300001822966us-gaap:CommonClassAMembersmr:ATMProgramMember2024-06-300001822966us-gaap:CommonClassAMemberus-gaap:SubsequentEventMembersmr:ATMProgramMember2024-07-012024-08-080001822966smr:PublicWarrantMember2024-06-300001822966smr:WarrantRedemptionScenarioOneMember2024-06-300001822966smr:WarrantRedemptionScenarioOneMember2024-01-012024-06-300001822966smr:WarrantRedemptionScenarioTwoMember2024-06-300001822966smr:WarrantRedemptionScenarioTwoMember2024-01-012024-06-300001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966smr:PublicWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966us-gaap:FairValueMeasurementsRecurringMember2024-06-300001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PublicWarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PublicWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966smr:PrivatePlacementWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966us-gaap:FairValueMeasurementsRecurringMember2023-12-310001822966us-gaap:FurnitureAndFixturesMember2024-06-300001822966us-gaap:FurnitureAndFixturesMember2023-12-310001822966smr:OfficeAndComputerEquipmentMember2024-06-300001822966smr:OfficeAndComputerEquipmentMember2023-12-310001822966us-gaap:SoftwareDevelopmentMember2024-06-300001822966us-gaap:SoftwareDevelopmentMember2023-12-310001822966us-gaap:TechnologyEquipmentMember2024-06-300001822966us-gaap:TechnologyEquipmentMember2023-12-310001822966us-gaap:LeaseholdImprovementsMember2024-06-300001822966us-gaap:LeaseholdImprovementsMember2023-12-310001822966smr:DepreciablePropertyPlantAndEquipmentMember2024-06-300001822966smr:DepreciablePropertyPlantAndEquipmentMember2023-12-310001822966us-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300001822966us-gaap:OtherExpenseMember2024-04-012024-06-300001822966us-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300001822966us-gaap:OtherExpenseMember2023-04-012023-06-300001822966us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001822966us-gaap:OtherExpenseMember2024-01-012024-06-300001822966us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001822966us-gaap:OtherExpenseMember2023-01-012023-06-300001822966smr:CFPPLLCMembersmr:LongLeadMaterialContractMember2023-03-310001822966smr:CFPPLLCMembersmr:LongLeadMaterialContractMember2023-11-070001822966smr:CFPPLLCMembersmr:LongLeadMaterialContractMember2023-12-310001822966smr:CFPPLLCMembersmr:LongLeadMaterialContractMember2024-06-300001822966us-gaap:ReclassificationOtherMember2024-06-300001822966smr:DefinedContributionPlanTrancheOneMember2024-01-012024-06-300001822966smr:DefinedContributionPlanTrancheTwoMember2024-01-012024-06-300001822966us-gaap:EmployeeStockOptionMember2024-04-012024-06-300001822966us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001822966us-gaap:EmployeeStockOptionMember2024-01-012024-06-300001822966us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:OtherExpenseMember2024-04-012024-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:OtherExpenseMember2023-04-012023-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:OtherExpenseMember2024-01-012024-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001822966us-gaap:EmployeeStockOptionMemberus-gaap:OtherExpenseMember2023-01-012023-06-300001822966us-gaap:EmployeeStockOptionMember2024-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2024-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001822966us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300001822966smr:ServicesPerformedMember2024-04-012024-06-300001822966smr:ServicesPerformedMember2023-04-012023-06-300001822966smr:ServicesPerformedMember2024-01-012024-06-300001822966smr:ServicesPerformedMember2023-01-012023-06-300001822966us-gaap:RelatedPartyMember2024-06-300001822966us-gaap:RelatedPartyMember2023-12-310001822966us-gaap:RelatedPartyMember2024-04-012024-06-300001822966us-gaap:RelatedPartyMember2023-04-012023-06-300001822966us-gaap:RelatedPartyMember2024-01-012024-06-300001822966us-gaap:RelatedPartyMember2023-01-012023-06-300001822966us-gaap:RelatedPartyMembersmr:FluorMember2024-04-012024-06-300001822966us-gaap:RelatedPartyMembersmr:FluorMember2023-04-012023-06-300001822966us-gaap:RelatedPartyMembersmr:FluorMember2024-01-012024-06-300001822966us-gaap:RelatedPartyMembersmr:FluorMember2023-01-012023-06-3000018229662022-09-192022-09-1900018229662023-11-152023-12-260001822966smr:JoseReyesJr.Member2024-01-012024-06-300001822966smr:JoseReyesJr.Member2024-04-012024-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 10-Q
______________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____________ to ____________
Commission file number 001-04321
______________________
NUSCALE POWER CORPORATION
(Exact name of registrant as specified in its charter)
______________________
Delaware98-1588588
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)
12725 SW 66th Ave Suite 107PortlandOregon97223
(Address of Principal Executive Offices)(Zip Code)
(971) 371-1592
Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, $0.0001 par value per share
SMR
New York Stock Exchange
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
SMR.WS
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
Non-accelerated filero
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

APPLICABLE ONLY TO CORPORATE ISSUERS:
The registrant had 94,715,714 Class A common shares, $0.0001 par value, and 154,464,735 Class B common shares, $0.0001 par value, outstanding as of August 5, 2024.



Table of Contents



Glossary

The definitions and abbreviations set forth below apply to the indicated terms used throughout this filing.

“ATM Program” refers to the program, implemented in connection with the Sales Agreement, dated August 9, 2023, between NuScale Power Corporation, Cowen & Company, LLC, B. Riley Securities, Inc. and Canaccord Genuity LLC as sales agents, under which the Company may offer and sell shares of the Company’s Class A common stock having an aggregate sales price of up to $150,000,000 from time to time
“CFPP LLC” refers to Carbon Free Power Project, LLC, an entity wholly owned by UAMPS.
“CFPP” refers to the Carbon Free Power Project.
“Class A common stock” refers to shares of Class A common stock, par value $0.0001 per share, of NuScale Power Corporation.
“Class B common stock” refers to shares of Class B common stock, par value $0.0001 per share, of NuScale Power Corporation, which represents the right to one vote per share and carries no economic rights.
“Combined interests” refers to the combination of shares of Class B common stock and NuScale LLC Class B units required to be exchanged for Class A common stock.
“Common stock” refers collectively to shares of Class A common stock and Class B common stock.
“DCA” refers to Design Certification Application
“DCRA” refers to the Development Cost Reimbursement Agreement, as amended, entered into with CFPP LLC
“DOE” refers to the U.S. Department of Energy.
“Exchange Act” refers to the Securities Exchange Act of 1934, as amended.
“Fluor” refers to Fluor Enterprises, Inc., a California corporation, which is wholly owned by Fluor
Corporation (NYSE: FLR).
“GAAP” refers to United States Generally Accepted Accounting Principles.
“G&A” expenses refers to general and administrative expenses.
“IPO” or “Initial Public Offering” refers to the initial public offering of Spring Valley, which closed on
November 27, 2020.
“Legacy NuScale Equityholders” refers to the holders of NuScale LLC Class B units.
“LLM Agreement” refers to the Long Lead Material Reimbursement Agreement, dated February 28, 2023, entered into between NuScale LLC and CFPP LLC.
“Merger” refers to the merger of Merger Sub with and into NuScale LLC, with NuScale LLC as the surviving entity.
“Merger Agreement” refers to the Agreement and Plan of Merger, dated as of December 13, 2021 (as amended, modified, supplemented or waived from time to time), between Spring Valley, Merger Sub and NuScale LLC.
“Merger Sub” refers to Spring Valley Merger Sub, LLC, an Oregon limited liability company and a
wholly owned subsidiary of Spring Valley.
“MWe” refers to one million watts of electric power.
“NPM” refers to NuScale Power Module™.
“NRC” refers to the U.S. Nuclear Regulatory Commission.
“NuScale Corp” refers to NuScale Power Corporation, a Delaware corporation and the combined company following the consummation of the Transaction, and its consolidated subsidiaries, including NuScale LLC.
“NuScale LLC” refers to NuScale Power, LLC, an Oregon limited liability company.
“NuScale LLC Class B Units” refers to non-voting, Class B units of NuScale LLC.
“Private Placement Warrants” refers to the 8,900,000 warrants to purchase Spring Valley Class A ordinary shares that
were issued in a private placement concurrently with the IPO and converted in the Transaction into warrants to purchase Class A common stock.
“Public Warrants” refers to the 11,500,000 redeemable warrants to purchase Spring Valley Class A ordinary shares that were issued in the IPO and converted in the Transaction
into warrants to purchase Class A common stock.
“R&D” refers to research and development.
“RSUs” refers to restricted stock units.
“Release Agreement” refers to the Confidential Settlement and Release Agreement, dated November 7, 2023, entered into between NuScale LLC and CFPP LLC.
“SDA” refers to Standard Design Approval.
“SMR” refers to small modular reactor.
“Spring Valley” refers to NuScale Corp prior to the Merger and prior to the change of its name from Spring Valley Acquisition Corp. to NuScale Power Corporation.
“Tax Receivable Agreement” or “TRA” refers to the tax receivable agreement entered into concurrently with the consummation of the Transaction between NuScale Corp, NuScale LLC and the Legacy NuScale Equityholders.
“Transaction” refers to the transactions contemplated by the Merger Agreement during the 2022 fiscal year.
“UAMPS” refers to the Utah Associated Municipal Power Systems.
“Warrant Agreement” refers to the Warrant Agreement, dated November 23, 2020, by and between Spring Valley and Continental Stock Transfer & Trust Company.



“Warrants” refers collectively to the Public Warrants and the Private Placement Warrants.







Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q, including, without limitation, statements regarding our financial position and business strategy and the expectations, beliefs, intentions, plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “continue,” “could,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “will,” “would,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report may include, for example, statements about:
our need for and ability to obtain additional equity financing or other sources of funding;
our financial and business performance, including financial projections and business metrics;
the ability to obtain regulatory approvals to deploy our SMRs in the United States and abroad;
forecasts regarding end-customer adoption rates and demand for our products in markets that are new and rapidly evolving;
macroeconomic conditions;
developments and projections relating to our competitors and industry;
our anticipated growth rates and market opportunities;
litigation contingencies;
the estimated amounts to be reimbursed to CFPP LLC and costs related to termination of the DCRA and LLM Agreement;
our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and
the potential for our business development efforts to maximize the potential value of our portfolio.

Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. Many factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, and there can be no assurance that future developments affecting us will be those we have anticipated.

Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, are described in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Form 10-K”). If one or more of those risks or uncertainties materialize, or if any of our assumptions prove incorrect, actual results may vary in material respects from those projected in those forward-looking statements. There may be additional risks that we currently consider immaterial, or which are unknown. It is not possible to predict or identify all such risks. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No person should take any statement regarding past trends or activities as a representation that the trends or activities will continue in the future.



Part I - Financial Information
Item 1. Financial Statements
NuScale Power Corporation
Condensed Consolidated Balance Sheet
(in thousands, except share and per share amounts)
June 30, 2024December 31, 2023
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents$130,934 $120,265 
Restricted cash5,100 5,100 
Prepaid expenses11,866 19,054 
Accounts and other receivables8,375 10,127 
   Total current assets156,275 154,546 
Property, plant and equipment, net3,150 4,116 
In-process research and development16,900 16,900 
Intangible assets, net793 882 
Goodwill8,255 8,255 
Long-lead material work in process41,227 36,361 
Other assets2,633 3,798 
   Total Assets$229,233 $224,858 
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses$19,098 $44,925 
Accrued compensation5,734 8,546 
Long-lead material liability32,445 32,323 
Other accrued liabilities1,540 1,664 
   Total current liabilities58,817 87,458 
Warrant liabilities51,500 5,722 
Noncurrent accounts payable and accrued expenses24,880  
Other noncurrent liabilities647 1,442 
Deferred revenue78 898 
   Total Liabilities135,922 95,520 
Stockholders’ Equity
Class A common stock, par value $0.0001 per share, 332,000,000 shares authorized, 92,486,358 and 76,895,166 shares outstanding as of June 30, 2024 and December 31, 2023, respectively
9 8 
Class B common stock, par value $0.0001 per share, 179,000,000 shares authorized, 154,464,735 and 154,477,032 shares outstanding as of June 30, 2024 and December 31, 2023, respectively
15 15 
Additional paid-in capital420,948 333,888 
Accumulated deficit(284,643)(240,454)
   Total Stockholders’ Equity Excluding Noncontrolling Interests136,329 93,457 
Noncontrolling interests(43,018)35,881 
   Total Stockholders' Equity93,311 129,338 
   Total Liabilities and Stockholders' Equity$229,233 $224,858 
The accompanying notes are an integral part of these financial statements.
1


NuScale Power Corporation
Condensed Consolidated Statements of Operations
(Unaudited)
(in thousands, except share and per share amounts)
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Revenue$967 $5,795 $2,346 $11,300 
Cost of sales(850)(5,765)(1,585)(9,181)
    Gross Margin117 30 761 2,119 
Research and development expenses12,132 26,932 25,287 54,502 
General and administrative expenses16,827 16,323 36,186 31,018 
Other expenses13,036 12,896 25,139 28,192 
    Loss From Operations(41,878)(56,121)(85,851)(111,593)
Sponsored cost share2,448 16,337 5,844 34,210 
Change in fair value of warrant liabilities(36,733)7,199 (45,778)6,091 
Interest income1,725 2,851 3,267 5,948 
   Loss Before Income Taxes(74,438)(29,734)(122,518)(65,344)
Provision (benefit) for income taxes    
   Net Loss(74,438)(29,734)(122,518)(65,344)
Net loss attributable to noncontrolling interests(46,821)(20,211)(78,329)(44,859)
Net Loss Attributable to Class A Common Stockholders$(27,617)$(9,523)$(44,189)$(20,485)
Loss per Share of Class A Common Stock:
Basic and Diluted$(0.31)$(0.13)$(0.52)$(0.29)
Weighted-Average Shares of Class A Common Stock Outstanding:
Basic and Diluted89,553,679 72,125,375 84,569,371 70,913,646 
The accompanying notes are an integral part of these financial statements.
2


NuScale Power Corporation
Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in thousands)Common Stock
Class AClass BAdditional Paid-in CapitalAccumulated DeficitNoncontrolling InterestsTotal
Stockholders’
Equity
SharesAmountSharesAmount
Balances at March 31, 2024 (Unaudited)86,760 $9 154,473 $15 $382,068 $(257,026)$3,625 $128,691 
Equity-based compensation expense— — — — 4,278 — — 4,278 
Exercise of common share options and warrants and vested RSUs1,520 — — — 3,754 — — 3,754 
Issuance of Class A common stock4,198 — — — 31,026 — — 31,026 
Exchange of combined interests into Class A common stock8 — (8)— — — —  
Rebalancing of ownership percentage for exchange of combined interest into Class A shares— — — — (178)— 178  
Net loss— — — — — (27,617)(46,821)(74,438)
Balances at June 30, 2024 (Unaudited)92,486 $9 154,465 $15 $420,948 $(284,643)$(43,018)$93,311 


(in thousands)Common Stock
Class AClass BAdditional Paid-in CapitalAccumulated DeficitNoncontrolling InterestsTotal
Stockholders’
Equity
SharesAmountSharesAmount
Balances at December 31, 202376,895 $8 154,477 $15 $333,888 $(240,454)$35,881 $129,338 
Equity-based compensation expense— — — — 6,496 — — 6,496 
Exercise of common share options and warrants and vested RSUs2,882 — — — 7,354 — — 7,354 
Issuance of Class A common stock12,697 1 — — 72,640 — — 72,641 
Exchange of combined interests into Class A common stock12 — (12)— — — —  
Rebalancing of ownership percentage for exchange of combined interest into Class A shares— — — — 570 — (570) 
Net loss— — — — — (44,189)(78,329)(122,518)
Balances at June 30, 2024 (Unaudited)92,486 $9 154,465 $15 $420,948 $(284,643)$(43,018)$93,311 


3


NuScale Power Corporation
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(in thousands)Common Stock
Class AClass BAdditional Paid-in CapitalAccumulated DeficitNoncontrolling InterestsTotal
Stockholders’
Equity
SharesAmountSharesAmount
Balances at March 31, 2023 (Unaudited)70,061 $7 157,091 $16 $302,487 $(193,054)$137,275 $246,731 
Equity-based compensation expense— — — — 4,453 — — 4,453 
Exercise of common share options, warrants and vested RSUs1,613 — — — 2,754 — — 2,754 
Exchange of combined interests into Class A common stock2,371 — (2,371)— — — —  
Rebalancing of ownership percentage for exchange of combined interest into Class A shares— — — — 2,924 — (2,924) 
Net loss— — — — — (9,523)(20,211)(29,734)
Balances at June 30, 2023 (Unaudited)74,045 $7 154,720 $16 $312,618 $(202,577)$114,140 $224,204 

(in thousands)Common Stock
Class AClass BAdditional Paid-in CapitalAccumulated DeficitNoncontrolling InterestsTotal
Stockholders’
Equity
SharesAmountSharesAmount
Balances at December 31, 202269,353 $7 157,091 $16 $296,748 $(182,092)$162,408 $277,087 
Equity-based compensation expense— — — — 8,090 — — 8,090 
Exercise of common share options, warrants and vested RSUs2,321 — — — 4,371 — — 4,371 
Exchange of combined interests into Class A common stock2,371 — (2,371)— — — —  
Rebalancing of ownership percentage for exchange of combined interest into Class A shares— — — — 3,409 — (3,409) 
Net loss— — — — (20,485)(44,859)(65,344)
Balances at June 30, 2023 (Unaudited)74,045 $7 154,720 $16 $312,618 $(202,577)$114,140 $224,204 
The accompanying notes are an integral part of these financial statements.
4


NuScale Power Corporation
Condensed Consolidated Statements of Cash Flows 
(Unaudited)
(in thousands)
Six Months Ended June 30,
20242023
OPERATING CASH FLOW
   Net Loss$(122,518)$(65,344)
Adjustments to reconcile net loss to operating cash flow:
   Depreciation892 1,172 
   Amortization of intangibles89 89 
   Equity-based compensation expense6,496 8,090 
   Impairment of intangible asset71  
   Gain on insurance proceeds received for damage to property, plant and equipment(122) 
   Change in fair value of warrant liabilities 45,778 (6,091)
   Net noncash change in right of use assets and lease liabilities(187)10 
Changes in assets and liabilities:
      Prepaid expenses and other assets7,676 (2,567)
      Accounts receivable1,752 (13,721)
      Long-term contract work in process(4,866)(23,900)
      Long-lead material liability122  
      Accounts payable and accrued expenses(273)327 
      Lease liability(799)(720)
      Deferred revenue(820)22,923 
      Accrued compensation(2,812)(2,635)
   Net Cash Used in Operating Activities(69,521)(82,367)
INVESTING CASH FLOW
Sale of short-term investments 50,000 
Insurance proceeds received for damage to property, plant and equipment195  
Purchases of property, plant and equipment (1,620)
   Net Cash Provided by Investing Activities195 48,380 
FINANCING CASH FLOW
Proceeds from the issuance of common stock, net of issuance fees72,641  
Proceeds from exercise of warrants and common share options7,354 4,371 
   Net Cash Provided by Financing Activities79,995 4,371 
   Net Change in Cash, Cash Equivalents and Restricted Cash10,669 (29,616)
Cash, cash equivalents and restricted cash:
Beginning of period125,365 244,217 
End of period$136,034 $214,601 
Summary of Noncash Investing and Financing Activities:
Plant, property and equipment in accounts payable 19 
The accompanying notes are an integral part of these financial statements.
5


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)

1.Nature of Business
Organization
NuScale Corp (“NuScale”, the “Company”, “us”, “we” or “our”) is incorporated under the laws of the state of Delaware. The Company is the primary beneficiary of NuScale LLC, a variable interest entity, and all activity of NuScale LLC and the Company are consolidated herein. NuScale LLC is a limited liability company organized in the State of Oregon in 2011. The Company is majority owned by Fluor Enterprises, Inc., a subsidiary of Fluor Corporation.
Operations
The Company is commercializing a modular, scalable 77 megawatt (gross) electric Light Water Reactor nuclear power plant using exclusive rights to a nuclear power plant design obtained from Oregon State University (“OSU”). The following represents key milestones in the development of this technology:
December 2016: DCA completed
January 2017: DCA submitted to the NRC
March 2017: DCA accepted for review by the NRC
August 2020: NRC issued the Final Safety Evaluation Report ("FSER")
July 2023: SDA Application and associated licensing topical reports accepted for formal review by the NRC
The FSER represents the NRC’s completion of its technical review and approval of the NuScale SMR design. With this final phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NuScale design. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval to be received by July 31, 2025.
The majority of the Company’s operations and long-lived assets were attributable to operations in the United States other than the long-lead material work in process being manufactured in South Korea during the 2023 and 2024 fiscal years.

On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3,236 during the six months ended June 30, 2024.

As a result of the cost-cutting plans implemented by management, the utilization of our ATM Program and the execution of a customer contract subsequent to June 30, 2024, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months.

Subsequent to June 30, 2024, the Company executed a revenue generating agreement with RoPower Nuclear S.A. (“RoPower”) in relation to the advancement of Doicesti project Phase 2 Front-End Engineering Design, a project which targets the development of six NuScale power modules at a former coal plant site in Doicești, Romania.
2.Summary of Significant Accounting Policies

Basis of Presentation
The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
6


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented.

Principles of Consolidation

As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale LLC, a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid assets. All significant intercompany transactions have been eliminated upon consolidation.

Changes in Presentation

For the six months ended June 30, 2023, amounts totaling $1,855 were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.

Cash, Cash Equivalents and Restricted Cash

Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.

Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at June 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows.
Sales and Marketing Agreements

The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of June 30, 2024 and December 31, 2023, the balance of $7,500 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024.

Warrant Liability

The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price.

Sponsored Cost Share

As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities.
7


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
As of June 30, 2024, these entities include the United States Department of State and United States Trade and Development Agency (combined as “USG”), RoPower, DOE and CFPP LLC.

Beginning in 2021, the Company partnered with USG to develop SMRs in foreign markets. Under USG’s technical assistance grant programs, we receive cost share commitments to support licensing work in these foreign markets, one of which is additionally supported by RoPower. During the three months ended June 30, 2024 and 2023, USG cost share totaled $2,397 and $6,882, respectively, while during the six months ended June 30, 2024 and 2023, USG cost share totaled $5,192 and $9,297, respectively.

Since 2014, DOE has provided critical funding to the Company through a series of cooperative agreements that support ongoing commercialization activities. Although we did not receive any cost share from DOE during the second quarter, during the six months ended June 30, 2024, DOE cost share totaled $336. During the three and six months ended June 30, 2023, DOE cost share totaled $7,193 and $19,547, respectively.

Finally, we receive subrecipient cost share from CFPP LLC under a contract between the DOE and UAMPS for R&D performed with the goal of developing our first SMR. Under this agreement we received cost share of $51 and $2,165 during the three months ended June 30, 2024 and 2023, respectively, while for the six months ended June 30, 2024 and 2023, the Company received cost share of $316 and $5,104, respectively.

Recent Accounting Pronouncements
Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.
3.Noncontrolling Interests and Loss Per Share
Noncontrolling Interests

Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders.

8


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
Noncontrolling Interests2024202320242023
NuScale Corp Class A common stock
Beginning of period86,760,24370,061,05576,895,16669,353,019
Exchange of combined interests into Class A common stock8,6602,370,80512,2972,370,805
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period92,486,35874,045,20692,486,35874,045,206
NuScale LLC Class B Units (NCI)
Beginning of period154,473,395157,090,820154,477,032157,090,820
Exchange of combined interests into Class A common stock(8,660)(2,370,805)(12,297)(2,370,805)
End of period154,464,735154,720,015154,464,735154,720,015
Total
Beginning of period241,233,638227,151,875231,372,198226,443,839
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period246,951,093228,765,221246,951,093228,765,221
Ownership Percentage
NuScale Corp Class A common stock
Beginning of period36.0 %30.8 %33.2 %30.6 %
End of period37.5 %32.4 %37.5 %32.4 %
NuScale LLC Class B Units (NCI)
Beginning of period64.0 %69.2 %66.8 %69.4 %
End of period62.5 %67.6 %62.5 %67.6 %
The NCI may decrease according to the number of shares of Class B common stock and NuScale LLC Class B units that are exchanged for shares of Class A common stock or, in certain circumstances including at the election of NuScale Corp, cash in an amount equal to the fair value of Class A common stock received in a contemporaneous equity issuance. After each exchange, NuScale LLC equity attributable to NuScale Corp is rebalanced to reflect the change in ownership percentage, which is calculated above based on Class B units and Class A shares, as a percentage of Combined interests.

Loss Per Share

Basic loss per share is based on the average number of shares of Class A common stock outstanding during the period. Diluted loss per share is based on the average number of shares of Class A common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of RSUs, Stock Options and Warrants using the “treasury stock”
9


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
method and for all other interests that convert into potential shares of Class A common stock, if any, using the “if converted” method. Net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the Company’s share of NuScale LLC’s net loss, net of NuScale Corp taxes, after giving effect to all other interests that convert into potential shares of Class A common stock, to the extent it is dilutive. In addition, net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the after-tax impact of changes to the fair value of derivative liabilities, to the extent the Company’s Warrants are dilutive.

The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented.
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
(in thousands, except share and per share amounts)2024202320242023
Net loss attributable to Class A common stockholders$(27,617)$(9,523)$(44,189)$(20,485)
Weighted-average shares for basic and diluted loss per share89,553,679 72,125,375 84,569,371 70,913,646 
Basic and Diluted loss per share of Class A common stock$(0.31)$(0.13)$(0.52)$(0.29)
Anti-dilutive securities excluded from shares outstanding:
    Shares of Class B common stock154,464,735 154,720,015 154,464,735 154,720,015 
    Stock options9,884,004 10,413,895 9,884,004 10,413,895 
    Warrants18,458,701 18,458,701 18,458,701 18,458,701 
    Time-based RSUs5,975,343 3,301,761 5,975,343 3,301,761 
Total188,782,783 186,894,372 188,782,783 186,894,372 

During the three and six months ended June 30, 2024, the Company issued and sold shares of Class A common stock in the amount of 4,198,064 and 12,696,994, respectively, at a weighted average price of $7.58 and $5.87 per share, respectively. During the three months ended June 30, 2024, the ATM Program generated gross and net proceeds of $31,821 and $31,025, respectively, while for the six months ended June 30, 2024 the ATM Program generated gross and net proceeds of $74,502 and $72,639, respectively. As of June 30, 2024, we have 5,565,628 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $65,142.

Subsequent to June 30, 2024, the Company issued and sold 1,420,391 shares of Class A common stock under the ATM Program for the gross and net proceeds of $18,858 and $18,386, respectively.
4.Warrant Liabilities

Under the Company’s Warrant Agreement, when Private Placement Warrants are transferred by Spring Valley Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), to persons who are not “Permitted Transferees” (as defined in the Warrant Agreement) of the Sponsor, they cease to be Private Placement Warrants and become Public Warrants under the Warrant Agreement. The Company has been informed by the Sponsor that the Private Placement Warrants were transferred in accordance with the Warrant Agreement to persons who are not Permitted Transferees. Consequently, the previously described Private Placement Warrants are now Public Warrants under the Warrant Agreement, resulting in all 18,458,701 warrants identified as Public Warrants in Note 5, Fair Value Measurement, as of June 30, 2024.

10


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants are currently exercisable and will expire on May 2, 2027 (five years from the date of the Transaction) or earlier upon redemption or liquidation.

Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00. The Company may redeem the outstanding Warrants:
in whole and not in part;
at a price of $0.01 per Warrant;
upon a minimum of 30 days prior written notice of redemption to each Warrant holder; and
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.

The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00. The Company may redeem the outstanding Warrants:
in whole and not in part;
at $0.10 per Warrant upon a minimum of 30 days prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined as set forth in the Warrant Agreement, based on the redemption date and the fair market value of the Class A common stock, subject to certain exceptions; and
if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant based on anti-dilution adjustments set forth in the Warrant Agreement) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.

The Warrants may be exercised for cash (or on a cashless basis as described above in “-Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00) at any time after notice of redemption shall have been given by the Company and prior to the redemption date.

For a complete description of the Warrants, please see the Warrant Agreement, which is Exhibit 4.2 to the 2023 Form 10-K, and the section entitled “Warrants” in the “Description of Registrant’s Securities,” which is Exhibit 4.3 to the 2023 Form 10-K.
5.Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach).
The levels of hierarchy are described below:
Level 1 Quoted prices in active markets for identical instruments;
11


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement.
The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities.

Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities, because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of June 30, 2024.

The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis:
(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities: 
   Public Warrants$51,500 $ $ $51,500 
Total Warrant Liabilities as of June 30, 2024$51,500 $ $ $51,500 

(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities:
   Public Warrants$2,963 $ $ $2,963 
   Private Placement Warrants 2,759  2,759 
Total Warrant Liabilities as of December 31, 2023$2,963 $2,759 $ $5,722 
6.Accounts and Other Receivables
Accounts and other receivables include reimbursement requests outstanding from the cost share awards, interest receivable and commercial accounts receivable. The cost share reimbursement requests are recognized as eligible costs are incurred. Reimbursement under the awards is recognized as award funds are obligated, and are included in Sponsored cost share in the condensed consolidated statement of operations. Interest receivable of $431 and $318 was outstanding at June 30, 2024 and December 31, 2023, respectively.

The majority of our receivables are either due from the U.S. federal government or have to do with a federal project. For these reasons, all receivables are deemed to be fully collectible and no allowance has been recorded.
12


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
7.Property, Plant and Equipment
Property, plant and equipment consisted of the following:
(in thousands)
June 30, 2024December 31, 2023
Furniture and fixtures$27 $27 
Office and computer equipment7,222 7,274 
Software13,898 14,102 
Operations equipment1,165 1,165 
Leasehold improvements2,189 2,293 
24,501 24,861 
Less: Accumulated depreciation(21,351)(20,745)
Net property, plant and equipment$3,150 $4,116 
Depreciation of property, plant and equipment for the three months ended June 30, 2024 and 2023 was $402 and $556, respectively. Of these amounts, $80 and $322 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $137 and $419, respectively, for the 2023 fiscal year.
Depreciation of property, plant and equipment for the six months ended June 30, 2024 and 2023 was $892 and $1,172, respectively. Of these amounts, $174 and $718 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $277 and $895, respectively, for the 2023 fiscal year.
8.Long-Lead Material Work In Process and Liability
During the first quarter of 2023, we entered into the LLM Agreement with CFPP LLC. Related to this contract, the Company has subcontracted for the purchase of certain long-lead materials (“LLM”) in the amount of $55,700, that were to be used in fabrication of the NPMs as part of the DCRA with CFPP LLC. However, on November 7, 2023, NuScale and CFPP LLC entered into the Release Agreement whereby the DCRA and LLM Agreement would be suspended, while wind down procedures and the ultimate disposition of the long-lead materials would be negotiated between the Company, CFPP LLC and DOE. As part of the Release Agreement, NuScale was required to pay $49,769 to CFPP LLC and provide a letter of credit in the amount of $5,000 for demobilization and wind down costs. This letter of credit is collateralized by $5,100 and included in the accompanying condensed consolidated balance sheet as Restricted cash as of June 30, 2024 and December 31, 2023.

Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations of the LLM. As a result of DOE’s investment in the LLM, as of June 30, 2024 and December 31, 2023, NuScale has included a Long-lead material liability on the accompanying condensed consolidated balance sheet in the amount of $32,445, for the estimated cost to gain 100% of the LLM, once completed. The LLM represents in process inventory recorded at cost and is identified as Long-lead material work in process on the condensed consolidated balance sheet in the amount of $41,227 and $36,361 as of June 30, 2024 and December 31, 2023, respectively.
9.Noncurrent Accounts Payable and Accrued Expenses
During the three months ended June 30, 2024, a contract with one of NuScale’s LLM manufacturing vendors was renegotiated as a result of the Release Agreement with CFPP LLC. This amendment resulted in new production milestones, with interest-free payments expected between July 2025 and December 2025. Should the payments be deferred to a later date, interest will begin accruing on January 1, 2026. As a result, we have reclassified $24,880 out of Accounts payable and accrued expenses into Noncurrent accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet.
13


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
10.Employee Benefits
The Company sponsors a defined contribution 401(k) Plan with contributions to be made at the sole discretion of the management. Under the provisions of the 401(k) Plan, the Company matches the employees’ contributions for the first 3% of compensation and matches 50% of the employees’ contributions for the next 2% of compensation. The expense recorded for the 401(k) Plan was $526 and $691 for the three months ended June 30, 2024 and 2023, respectively, and $1,139 and $1,442 for the six months ended June 30, 2024 and 2023, respectively.
11.Income Taxes
NuScale LLC was historically and remains a partnership for U.S. federal income tax purposes with each partner being separately taxed on its share of taxable income or loss. NuScale Corp is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of any net taxable income or loss and any related tax credits of NuScale LLC.

The effective tax rate was 0% for the three and six months ended June 30, 2024. The effective income tax rate for the three and six months ended June 30, 2024 differed significantly from the statutory rates, primarily due to the losses allocated to NCI and the recognition of a valuation allowance as a result of the Company’s new tax structure following the Transaction.

There was no income tax expense recorded during the three and six months ended June 30, 2024.

The Company has assessed the realizability of the net deferred tax assets and in that analysis has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets at NuScale Corp as of June 30, 2024, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.

The Company’s income tax filings will be subject to audit by various taxing jurisdictions. The Company will monitor the status of U.S. federal, state and local income tax returns that may be subject to audit in future periods. No U.S. federal, state and local income tax returns are currently under examination by the respective taxing authorities.
12.Equity-Based Compensation

The total compensation expense recognized for common share options and time-based RSU awards during the three months ended June 30, 2024 and 2023 was $4,277 and $4,453, respectively, and $6,496 and $8,090 for the six months ended June 30, 2024 and 2023, respectively. For the three months ended June 30, 2024, equity-based compensation of $1,981 was included in G&A expense and $2,296 was included in Other expense, compared to $1,868 and $2,585, respectively, over the same periods in the prior year. For the six months ended June 30, 2024, equity based compensation of $3,428 was included in G&A expense and $3,068 included in Other expense compared to $3,361 and $4,729, respectively, over the same periods in the prior year.

Stock Options

During the six months ended June 30, 2024, the Board approved 2,909,375 employee share option awards, with an aggregate fair value of $6,401, that vest one-third annually starting in February 2025 for a period of three years.

The Company measures the fair value of each share option grant at the date of grant using a Black-Scholes option pricing model.

Time-based RSUs

14


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
During the six months ended June 30, 2024, the Company granted employees 4,598,635 RSUs with an aggregate value of $14,716. The RSUs vest one-third annually starting in February 2025. During the three and six months ended June 30, 2024, RSUs totaling 450,332 and 918,239, respectively, vested and the Class A shares were issued.

13.Related Party Transactions
From time to time, the Company enters into strategic agreements with Fluor, whereby Fluor or the Company perform services for one another. For the three months ended June 30, 2024 and 2023, we incurred expenses of $291 and $8,479, respectively, while for the six months ended June 30, 2024 and 2023, we incurred expenses of $538 and $17,205, respectively. As of June 30, 2024 and December 31, 2023, the Company owed Fluor, as Accounts payable and accrued expenses on the condensed consolidated balance sheet, amounts totaling $1,233 and $4,080, respectively. For the three months ended June 30, 2024 and 2023, we earned revenue of $523 and $4,756, respectively, and for the six months ended June 30, 2024 and 2023, we earned $523 and $8,770, respectively. As of June 30, 2024 and December 31, 2023, Fluor owed us $523 and $2,642, respectively, amounts which are included in Accounts and other receivables on the condensed consolidated balance sheet.

For the three months ended June 30, 2024 and 2023, Fluor accounted for 54% and 82%, respectively, of total revenue, while for the six months ended June 30, 2024 and 2023, they accounted for 22% and 78%, respectively.
14.Commitments and Contingencies
In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations.

On September 19, 2022, thirteen purported members of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with the Merger between NuScale LLC and Spring Valley Acquisition Corp. NuScale LLC filed a motion to dismiss the complaint on November 21, 2022. Plaintiffs filed a response on January 17, 2023, and NuScale LLC filed a reply on February 14, 2023. A hearing on various motions to dismiss took place on May 17, 2023, and on August 3, 2023, the Magistrate Judge assigned to the case issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to the report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, Plaintiffs filed a motion for leave to amend their complaint, seeking to add claims and bring back defendants that were dismissed from the complaint at an earlier stage of the litigation (Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC). NuScale LLC and the other defendants opposed the proposed amendment. On May 2, 2024, the Magistrate Judge issued a report and recommendation that recommended that Plaintiffs’ proposed amendment be denied. Plaintiffs did not file an objection to this report, and it was adopted by the District Court Judge on June 24, 2024. That same day, the Court ordered that the parties confer and provide proposed dates for completing discovery and filing any dispositive motions. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

Two other shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company, John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court has appointed lead plaintiff and lead counsel, and they filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants’ filed a
15


NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
motion to dismiss on June 17, 2024. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

In connection with DOE and UAMPS Award 8935, DOE designated NuScale as a subrecipient to UAMPS for the production of NPM 1, while classifying NuScale as a contractor or subcontractor for NPMs 2-6. As part of DOE’s classification of NuScale as a contractor or subcontractor for NPMs 2-6, DOE noted that should NuScale fail to initiate commercial operation of NPM 1, DOE has the right to demand repayment of the fees invoiced for NPMs 2-6.


16


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the financial condition and results of operations of NuScale Power Corporation should be read together with our financial statements as of and for the years ended December 31, 2023 and 2022 and our unaudited interim condensed consolidated financial statements as of and for the three and six months ended June 30, 2024 and 2023, together with related notes thereto. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those projected in these forward-looking statements as a result of various factors. As used herein, “NuScale,” “the Company,” “us,” “our” or “we” refer to NuScale Power Corporation, together with its consolidated subsidiaries.
Overview
Our mission is to provide scalable advanced nuclear technology to produce electricity, heat and clean water to improve the quality of life for people around the world. We are changing the power that changes the world by creating an energy source that is smarter, cleaner, safer and cost competitive.
Our small modular reactor (“SMR”), known as the NuScale Power Module (“NPM”), provides a scalable power plant solution incorporating enhanced safety, improved affordability and extended flexibility for diverse electrical and process heat applications. Our scalable design provides carbon-free energy at a reduced cost when compared with gigawatt-sized nuclear facilities.
Since our founding in 2007, we have made significant progress towards commercializing the first SMR in the United States. In 2017, we submitted our Design Certification Application (“DCA”) to the U.S. Nuclear Regulatory Commission (“NRC”). On August 28, 2020, the NRC issued its Final Safety Evaluation Report, representing the NRC’s completion of its technical review. On September 11, 2020, the NRC issued its Standard Design Approval (“SDA”) of our NPM and scalable plant design. With this phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NPM and plant design. We expect the Company will continue to experience operating losses and negative operating cash flow until the commercialization of the NPM. On January 19, 2023, the NRC published in the Federal Register a final rule that certifies NuScale’s SMR design for use in the United States, which became effective 30 days after publication.

In January 2023, the Company submitted a SDA Application and the associated licensing topical reports to the NRC for NuScale’s 6-unit 77 MWe NPM design. Once approved, customers in the United States will be able to reference the certified design and SDA for expedited construction and operating licensing of NuScale’s SMR pursuant to 10 CFR Part 52. On July 31, 2023, the NRC formally announced that it has accepted the Company’s SDA Application for formal review. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval will be received by July 31, 2025.

The Company currently has only one “Class 1” customer: RoPower Nuclear S.A. (“RoPower”), which is a joint venture established by S.N. Nuclearelectrica S.A. (“Nuclearelectrica”) and Nova Power & Gas S.A. In November 2023, we entered into the Release Agreement with CFPP LLC, the Company’s first customer, pursuant to which the Company agreed to terminate the Development Cost Reimbursement Agreement (“DCRA”), as amended, and our Long Lead Material Reimbursement Agreement (“LLM Agreement”). CFPP LLC was receiving funding for approximately 79% of its qualified project costs, including the long-lead materials (“LLM”), under a cooperative agreement with the Department of Energy (“DOE”). Under the Release Agreement, we agreed to repay CFPP LLC’s Net Development Costs. Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations associated with the LLM.


17


Results of Operations
(in thousands)Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Revenue$967 $5,795 $2,346 $11,300 
Cost of sales(850)(5,765)(1,585)(9,181)
    Gross Margin117 30 761 2,119 
Research and development expenses12,132 26,932 25,287 54,502 
General and administrative expenses16,827 16,323 36,186 31,018 
Other expenses13,036 12,896 25,139 28,192 
    Loss From Operations(41,878)(56,121)(85,851)(111,593)
Sponsored cost share2,448 16,337 5,844 34,210 
Change in fair value of warrant liabilities(36,733)7,199 (45,778)6,091 
Interest income1,725 2,851 3,267 5,948 
   Loss Before Income Taxes$(74,438)$(29,734)$(122,518)$(65,344)
Comparison of the Three Months Ended June 30, 2024 and 2023

Revenue and Cost of Sales

The decrease in revenue and cost of sales was attributable to the loss of the contract with CFPP LLC.

Research and Development

R&D expenses decreased as a result of $2.5 million in lower compensation costs associated with our transition from a R&D-based company to a commercial company, while we also had lower professional fees of $12.2 million due to the loss of the CFPP LLC contract and cost cutting measures.

Sponsored Cost Share
Sponsored cost share decreased due to decreased DOE funding and the loss of the CFPP LLC contract.

Change in Fair Value of Warrant Liabilities

The change resulted from a significant increase in the Company’s warrant price, consistent with the Company’s stock price, during the three months ended June 30, 2024.

Comparison of the Six Months Ended June 30, 2024 and 2023

Changes in Presentation

For the six months ended June 30, 2023, amounts totaling $1.9 million were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.

Revenue and Cost of Sales

The decrease in revenue and cost of sales was attributable to the loss of the contract with CFPP LLC.

Research and Development

18


R&D expenses decreased as a result of $3.9 million in lower compensation costs associated with our transition from a R&D-based company to a commercial company, while we also had lower professional fees of $25.1 million due to the loss of the CFPP contract and cost cutting measures.

General and Administrative
G&A expenses increased due to $1.4 million in compensation costs resulting from severance costs, partially offset by savings related to the workforce reduction. Further, we had $5.3 million higher strategic marketing expenses as we continue to target potential customers. These increases were partially offset by management successfully executing their strategy for controlling costs related to nonessential items.

Other

Other expenses decreased as a result of lower equity-based compensation in the amount of $1.6 million along with savings on nonessential expenses management has identified and eliminated.
Sponsored Cost Share
Sponsored cost share decreased as a result of the loss of the contract with CFPP LLC and decreased DOE funding in the current year.

Change in Fair Value of Warrant Liabilities

The change resulted from a significant increase in the Company’s warrant price during the six months ended June 30, 2024.
Liquidity and Capital Resources
During the three and six months ended June 30, 2024, the Company issued and sold shares of Class A common stock in the amount of 4,198,064 and 12,696,994, respectively, at a weighted average price of $7.58 and $5.87 per share, respectively. During the three months ended June 30, 2024, the ATM Program generated gross and net proceeds of $31.8 million and $31.0 million, respectively, while for the six months ended June 30, 2024 the ATM Program generated gross and net proceeds of $74.5 million and $72.6 million, respectively. As of June 30, 2024, we have 5,565,628 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $65.1 million.
Subsequent to June 30, 2024, the Company issued and sold 1,420,391 shares of Class A common stock under the ATM Program for the gross and net proceeds of $18,858 and $18,386, respectively.
Since NuScale’s inception, we have incurred significant operating losses and have an accumulated deficit of $284.6 million, with negative operating cash flows. As of June 30, 2024, we had cash and cash equivalents of $130.9 million and restricted cash of $5.1 million with no debt. Historically, our primary sources of cash included investment capital, DOE and other government sponsored cost share agreements to support the advancement of the Company’s SMR technology both domestically and abroad. As we transition from a focus on research and development to commercialization of our technology, the Company is focusing on commercial contracts that generate revenue. These factors combined with the execution of the Release Agreement with CFPP LLC have impacted our cash flow from operations during the period and our forecasted cash flow from operations during the remainder of the 2024 fiscal year. While we believe we have sufficient funds to reach commercialization of our NPM, certain costs are not reasonably estimable at this time, and we may require additional funding, which may not be available on terms acceptable to us or at all. Our projections anticipate certain customer-sourced income that is not assured and DOE funds which are subject to Congressional appropriations and dependent on the President signing it into law.

On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3.2 million during the six months ended June 30, 2024.

Subsequent to June 30, 2024, the Company executed a revenue generating agreement with RoPower in relation to the advancement of Doicesti project Phase 2 Front-End Engineering Design, a project which targets the development of six NuScale power modules at a former coal plant site in Doicești, Romania.

19


As a result of the cost-cutting plans implemented by management, the utilization of our ATM Program and the execution of a customer contract subsequent to June 30, 2024, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months. Further, management plans to prudently manage its expenses and cash reserves into the future, including beyond the next twelve months, recognizing the need to secure additional customer commitments to support long-term operations. For additional information regarding these risk factors, see the Company’s 2023 Form 10-K.
Comparison of Cash Flows for the Six Months Ended June 30, 2024 and 2023
The following table sets forth the primary sources and uses of cash and cash equivalents for the periods presented below:
Six Months Ended June 30,
(in thousands)20242023
   Net Cash Used in Operating Activities$(69,521)$(82,367)
   Net Cash Provided by Investing Activities195 48,380 
   Net Cash Provided by Financing Activities79,995 4,371 
Net change in cash and cash equivalents (A)
$10,669 $(29,616)
(A) Includes $5,100 in restricted cash
Cash Flows used in Operating Activities
Our cash used in operations improved during the six months ended June 30, 2024 due to lower payments for business development services and other efficiencies.
Cash Flows provided by Investing Activities
During the six months ended June 30, 2023 the Company sold a short-term investment for $50.0 million. Typically, investing activities will consist of capital expenditures, although during the six months ended June 30, 2024 NuScale received insurance proceeds for property, plant and equipment.

Cash Flows provided by Financing Activities
During the six months ended June 30, 2024, net cash provided by financing activities consisted of proceeds from the utilization of our ATM Program and the exercise of stock options, while during the six months ended June 30, 2023 the proceeds originated only from the exercise of stock options.
Capital Resources
Under the Release Agreement, the Company is required to have credit support to fund the amount of its potential reimbursement of demobilization and wind down costs with CFPP LLC. This account is identified as Restricted cash in the amount of $5.1 million on the accompanying condensed consolidated balance sheet and acts as collateral for the $5.0 million letter of credit outstanding at June 30, 2024.
In connection with DOE and UAMPS Award 8935, DOE designated NuScale as a subrecipient to UAMPS for the production of NPM 1, while classifying NuScale as a contractor or subcontractor for NPMs 2-6. As part of DOE’s classification of NuScale as a contractor or subcontractor for NPMs 2-6, DOE noted that should NuScale fail to initiate commercial operation of NPM 1, DOE has the right to demand repayment of the fees invoiced for NPMs 2-6.
Recent Accounting Pronouncements
Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
20


There have been no material changes from the discussion of the Company’s market risk in Part I, Item 7A., Quantitative and Qualitative Disclosures About Market Risk, of the Company’s 2023 Form 10-K.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of the evaluation date, our disclosure controls and procedures were effective as of June 30, 2024. Accordingly, management believes that the financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
21


Part II - Other Information
Item 1. Legal Proceedings

In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations.

On September 19, 2022, thirteen purported members of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with the Merger between NuScale LLC and Spring Valley Acquisition Corp. NuScale LLC filed a motion to dismiss the complaint on November 21, 2022. Plaintiffs filed a response on January 17, 2023, and NuScale LLC filed a reply on February 14, 2023. A hearing on various motions to dismiss took place on May 17, 2023, and on August 3, 2023, the Magistrate Judge assigned to the case issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to the report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, Plaintiffs filed a motion for leave to amend their complaint, seeking to add claims and to bring back defendants that were dismissed from the complaint at an earlier stage of the litigation (Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC). NuScale LLC and the other defendants opposed the proposed amendment. On May 2, 2024, the Magistrate Judge issued a report and recommendation that recommended that Plaintiffs’ proposed amendment be denied. Plaintiffs did not file an objection to this report, and it was adopted by the District Court Judge on June 24, 2024. That same day, the Court ordered that the parties confer and provide proposed dates for completing discovery and filing any dispositive motions. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

Two other shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company, John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court has appointed lead plaintiff and lead counsel, and they filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants filed a motion to dismiss on June 17, 2024. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

In December 2023, the Company received a voluntary request from the SEC’s Denver Regional Office for information relating to its employment, severance, and confidentiality agreements, which the Company understood to be a part of a broader inquiry involving multiple companies related to the SEC’s whistleblower provisions. The Company responded in January 2024 and had no further communications with the SEC. On July 30, 2024, the Company contacted the SEC following publication of an article by Hunterbrook Media. On July 31, 2024, the SEC made follow up requests for additional information relating to the December 2023 request. The Company is in the process of responding to those requests and intends to fully cooperate with the SEC. The Company cannot predict the timing or outcome of the SEC’s investigation at this time.
Item 1A. Risk Factors

We are and may become involved in litigation that may materially adversely affect us.

We are currently named in a number of purported class action lawsuits (see “Legal Proceedings”), and from time to time, we are and may become involved in various legal proceedings relating to other matters, including intellectual property, commercial, product liability, employment, class action, whistleblower and other litigation and claims, and governmental and other regulatory investigations and proceedings, such as the SEC’s current request for information regarding our employment, severance, and confidentiality agreements. Such matters can be time-consuming, divert management’s attention and resources from the operation of our business and cause us to incur significant expenses or liability or require us to change our business practices.

22


One of the existing shareholder class action lawsuits claims in part that NuScale LLC breached its prior LLC operating agreement or breached a duty of good faith and fair dealing in amending the LLC operating agreement in the Transaction without obtaining the consent of former common unit holders of NuScale LLC as a separate class. This class action lawsuit claims in part that the conversion of preferred units to common units, which occurred in conjunction with the merger, was inequitable to common unit holders. Plaintiffs are now seeking to amend their complaint to add a claim that this conversion itself breached the operating agreement.

The other shareholder class action lawsuit claims that NuScale and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. While two causes of action were filed, these lawsuits have been consolidated before the same judge in the federal district court in Oregon.

While we disagree with all of the plaintiffs’ claims included in the class action lawsuits, the risk of loss if plaintiffs prevail would be material to the Company. Because of the potential risks, expenses and uncertainties of litigation and investigations, we may, from time to time, settle disputes and other proceedings, even where we believe that we have meritorious claims or defenses. Because litigation and investigations are inherently unpredictable, we cannot assure you that the results of any of these actions will not have a material adverse effect on our business.

Please see the 2023 Form 10-K for a complete list of our risk factors.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable
Item 3. Defaults Upon Senior Securities
Not applicable
Item 4. Mine Safety Disclosures
Not applicable
Item 5. Other Information
Rule 10b5-1 Trading Plans

During the three months ended June 30, 2024, one officer of the Company, José Reyes Jr., terminated his 10b5-1 plan on April 23, 2024.
23


Item 6. Exhibits and Financial Statements Schedules
(a)Exhibits.
Exhibit
Number
Description
3.1
3.2
4.1
4.2
31.1
31.2
32.1
32.2
101 .INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL).
__________________________________________


24


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NuScale Power Corporation
DateBy:/s/ John Hopkins
August 9, 2024Name:John Hopkins
Title:Chief Executive Officer
DateBy:/s/ R. Ramsey Hamady
August 9, 2024NameR. Ramsey Hamady
Title:Chief Financial Officer
25


Exhibit 31.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, John Hopkins, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of NuScale Power Corporation;
  
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
 (c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
 (d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



 
 Date: August 9, 2024
By:/s/ John Hopkins
  John Hopkins
  Chief Executive Officer (Principal Executive Officer)




Exhibit 31.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, R. Ramsey Hamady, certify that:
 
1.I have reviewed this quarterly report on Form 10-Q of NuScale Power Corporation;
  
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
  
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
  
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
 (a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
 (b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
 (c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
 (d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 (a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
 (b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



 
 Date: August 9, 2024
By:/s/ R. Ramsey Hamady
  R. Ramsey Hamady
  Chief Financial Officer (Principal Financial Officer)




 
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 of NuScale Power Corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Hopkins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
 
 (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
 (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
August 9, 2024
/s/ John Hopkins
 John Hopkins
 Chief Executive Officer
 (Principal Executive Officer)




 
Exhibit 32.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 of NuScale Power, Inc. (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, R. Ramsey Hamady, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
 
 (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
 (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
August 9, 2024
/s/ R. Ramsey Hamady
 R. Ramsey Hamady
 Chief Financial Officer
 (Principal Financial Officer)


v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 05, 2024
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-04321  
Entity Registrant Name NUSCALE POWER CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-1588588  
Entity Address, Address Line One 12725 SW 66th Ave Suite 107  
Entity Address, City or Town Portland  
Entity Address, State or Province OR  
Entity Address, Postal Zip Code 97223  
City Area Code 971  
Local Phone Number 371-1592  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Central Index Key 0001822966  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Class A    
Entity Information [Line Items]    
Title of 12(b) Security Class A common stock, $0.0001 par value per share  
Trading Symbol SMR  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   94,715,714
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share    
Entity Information [Line Items]    
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share  
Trading Symbol SMR.WS  
Security Exchange Name NYSE  
Class B    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   154,464,735
v3.24.2.u1
Condensed Consolidated Balance Sheet - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 130,934 $ 120,265
Restricted cash 5,100 5,100
Prepaid expenses 11,866 19,054
Accounts and other receivables 8,375 10,127
Total current assets 156,275 154,546
Property, plant and equipment, net 3,150 4,116
In-process research and development 16,900 16,900
Intangible assets, net 793 882
Goodwill 8,255 8,255
Long-lead material work in process 41,227 36,361
Other assets 2,633 3,798
Total Assets 229,233 224,858
Current Liabilities    
Accounts payable and accrued expenses 19,098 44,925
Accrued compensation 5,734 8,546
Long-lead material liability 32,445 32,323
Other accrued liabilities 1,540 1,664
Total current liabilities 58,817 87,458
Warrant liabilities 51,500 5,722
Noncurrent accounts payable and accrued expenses 24,880 0
Other noncurrent liabilities 647 1,442
Deferred revenue 78 898
Total Liabilities 135,922 95,520
Stockholders’ Equity    
Additional paid-in capital 420,948 333,888
Accumulated deficit (284,643) (240,454)
Total Stockholders’ Equity Excluding Noncontrolling Interests 136,329 93,457
Noncontrolling interests (43,018) 35,881
Total Stockholders' Equity 93,311 129,338
Total Liabilities and Stockholders' Equity 229,233 224,858
Class A    
Stockholders’ Equity    
Common stock, value 9 8
Class B    
Stockholders’ Equity    
Common stock, value $ 15 $ 15
v3.24.2.u1
Condensed Consolidated Balance Sheet (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Class A    
Common stock, par value (usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (shares) 332,000,000 332,000,000
Common stock, shares outstanding (shares) 92,486,358 76,895,166
Class B    
Common stock, par value (usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (shares) 179,000,000 179,000,000
Common stock, shares outstanding (shares) 154,464,735 154,477,032
v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue $ 967,000 $ 5,795,000 $ 2,346,000 $ 11,300,000
Cost of sales (850,000) (5,765,000) (1,585,000) (9,181,000)
Gross Margin 117,000 30,000 761,000 2,119,000
Research and development expenses 12,132,000 26,932,000 25,287,000 54,502,000
General and administrative expenses 16,827,000 16,323,000 36,186,000 31,018,000
Other expenses 13,036,000 12,896,000 25,139,000 28,192,000
Loss From Operations (41,878,000) (56,121,000) (85,851,000) (111,593,000)
Sponsored cost share 2,448,000 16,337,000 5,844,000 34,210,000
Change in fair value of warrant liabilities (36,733,000) 7,199,000 (45,778,000) 6,091,000
Interest income 1,725,000 2,851,000 3,267,000 5,948,000
Loss Before Income Taxes (74,438,000) (29,734,000) (122,518,000) (65,344,000)
Provision (benefit) for income taxes 0 0 0 0
Net Loss (74,438,000) (29,734,000) (122,518,000) (65,344,000)
Net loss attributable to noncontrolling interests (46,821,000) (20,211,000) (78,329,000) (44,859,000)
Net Loss Attributable to Class A Common Stockholders $ (27,617,000) $ (9,523,000) $ (44,189,000) $ (20,485,000)
Loss per Share of Class A Common Stock:        
Basic (usd per share) $ (0.31) $ (0.13) $ (0.52) $ (0.29)
Diluted (usd per share) $ (0.31) $ (0.13) $ (0.52) $ (0.29)
Weighted-Average Shares of Class A Common Stock Outstanding:        
Basic (shares) 89,553,679 72,125,375 84,569,371 70,913,646
Diluted (shares) 89,553,679 72,125,375 84,569,371 70,913,646
v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Class A
Class B
Common Stock
Class A
Common Stock
Class B
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests
Beginning balance (shares) at Dec. 31, 2022       69,353,000 157,091,000      
Beginning balance at Dec. 31, 2022 $ 277,087     $ 7 $ 16 $ 296,748 $ (182,092) $ 162,408
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 8,090         8,090    
Exercise of common share options and warrants and vested RSUs (shares)       2,321,000        
Exercise of common share options and warrants and vested RSUs 4,371         4,371    
Exchange of combined interests into Class A common stock (shares)       2,371,000 (2,371,000)      
Exchange of combined interests into Class A common stock 0              
Rebalancing of ownership percentage for exchange of combined interest into Class A shares 0         3,409   (3,409)
Net loss (65,344)           (20,485) (44,859)
Ending balance (shares) at Jun. 30, 2023       74,045,000 154,720,000      
Ending balance at Jun. 30, 2023 224,204     $ 7 $ 16 312,618 (202,577) 114,140
Beginning balance (shares) at Mar. 31, 2023       70,061,000 157,091,000      
Beginning balance at Mar. 31, 2023 246,731     $ 7 $ 16 302,487 (193,054) 137,275
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 4,453         4,453    
Exercise of common share options and warrants and vested RSUs (shares)       1,613,000        
Exercise of common share options and warrants and vested RSUs 2,754         2,754    
Exchange of combined interests into Class A common stock (shares)       2,371,000 (2,371,000)      
Exchange of combined interests into Class A common stock 0              
Rebalancing of ownership percentage for exchange of combined interest into Class A shares 0         2,924   (2,924)
Net loss (29,734)           (9,523) (20,211)
Ending balance (shares) at Jun. 30, 2023       74,045,000 154,720,000      
Ending balance at Jun. 30, 2023 224,204     $ 7 $ 16 312,618 (202,577) 114,140
Beginning balance (shares) at Dec. 31, 2023   76,895,166 154,477,032 76,895,000 154,477,000      
Beginning balance at Dec. 31, 2023 129,338     $ 8 $ 15 333,888 (240,454) 35,881
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 6,496         6,496    
Exercise of common share options and warrants and vested RSUs (shares)       2,882,000        
Exercise of common share options and warrants and vested RSUs 7,354         7,354    
Issuance of Class A common stock (shares)       12,697,000        
Issuance of Class A common stock 72,641     $ 1   72,640    
Exchange of combined interests into Class A common stock (shares)       12,000 (12,000)      
Exchange of combined interests into Class A common stock 0              
Rebalancing of ownership percentage for exchange of combined interest into Class A shares 0         570   (570)
Net loss (122,518)           (44,189) (78,329)
Ending balance (shares) at Jun. 30, 2024   92,486,358 154,464,735 92,486,000 154,465,000      
Ending balance at Jun. 30, 2024 93,311     $ 9 $ 15 420,948 (284,643) (43,018)
Beginning balance (shares) at Mar. 31, 2024       86,760,000 154,473,000      
Beginning balance at Mar. 31, 2024 128,691     $ 9 $ 15 382,068 (257,026) 3,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 4,278         4,278    
Exercise of common share options and warrants and vested RSUs (shares)       1,520,000        
Exercise of common share options and warrants and vested RSUs 3,754         3,754    
Issuance of Class A common stock (shares)       4,198,000        
Issuance of Class A common stock 31,026         31,026    
Exchange of combined interests into Class A common stock (shares)       8,000 (8,000)      
Exchange of combined interests into Class A common stock 0              
Rebalancing of ownership percentage for exchange of combined interest into Class A shares 0         (178)   178
Net loss (74,438)           (27,617) (46,821)
Ending balance (shares) at Jun. 30, 2024   92,486,358 154,464,735 92,486,000 154,465,000      
Ending balance at Jun. 30, 2024 $ 93,311     $ 9 $ 15 $ 420,948 $ (284,643) $ (43,018)
v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
OPERATING CASH FLOW    
Net Loss $ (122,518) $ (65,344)
Adjustments to reconcile net loss to operating cash flow:    
Depreciation 892 1,172
Amortization of intangibles 89 89
Equity-based compensation expense 6,496 8,090
Impairment of intangible asset 71 0
Gain on insurance proceeds received for damage to property, plant and equipment (122) 0
Change in fair value of warrant liabilities 45,778 (6,091)
Net noncash change in right of use assets and lease liabilities (187) 10
Changes in assets and liabilities:    
Prepaid expenses and other assets 7,676 (2,567)
Accounts receivable 1,752 (13,721)
Long-term contract work in process (4,866) (23,900)
Long-lead material liability 122 0
Accounts payable and accrued expenses (273) 327
Lease liability (799) (720)
Deferred revenue (820) 22,923
Accrued compensation (2,812) (2,635)
Net Cash Used in Operating Activities (69,521) (82,367)
INVESTING CASH FLOW    
Sale of short-term investments 0 50,000
Insurance proceeds received for damage to property, plant and equipment 195 0
Purchases of property, plant and equipment 0 (1,620)
Net Cash Provided by Investing Activities 195 48,380
FINANCING CASH FLOW    
Proceeds from the issuance of common stock, net of issuance fees 72,641 0
Proceeds from exercise of warrants and common share options 7,354 4,371
Net Cash Provided by Financing Activities 79,995 4,371
Net Change in Cash, Cash Equivalents and Restricted Cash 10,669 (29,616)
Cash, cash equivalents and restricted cash:    
Beginning of period 125,365 244,217
End of period 136,034 214,601
Summary of Noncash Investing and Financing Activities:    
Plant, property and equipment in accounts payable $ 0 $ 19
v3.24.2.u1
Nature of Business
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business Nature of Business
Organization
NuScale Corp (“NuScale”, the “Company”, “us”, “we” or “our”) is incorporated under the laws of the state of Delaware. The Company is the primary beneficiary of NuScale LLC, a variable interest entity, and all activity of NuScale LLC and the Company are consolidated herein. NuScale LLC is a limited liability company organized in the State of Oregon in 2011. The Company is majority owned by Fluor Enterprises, Inc., a subsidiary of Fluor Corporation.
Operations
The Company is commercializing a modular, scalable 77 megawatt (gross) electric Light Water Reactor nuclear power plant using exclusive rights to a nuclear power plant design obtained from Oregon State University (“OSU”). The following represents key milestones in the development of this technology:
December 2016: DCA completed
January 2017: DCA submitted to the NRC
March 2017: DCA accepted for review by the NRC
August 2020: NRC issued the Final Safety Evaluation Report ("FSER")
July 2023: SDA Application and associated licensing topical reports accepted for formal review by the NRC
The FSER represents the NRC’s completion of its technical review and approval of the NuScale SMR design. With this final phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NuScale design. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval to be received by July 31, 2025.
The majority of the Company’s operations and long-lived assets were attributable to operations in the United States other than the long-lead material work in process being manufactured in South Korea during the 2023 and 2024 fiscal years.

On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3,236 during the six months ended June 30, 2024.

As a result of the cost-cutting plans implemented by management, the utilization of our ATM Program and the execution of a customer contract subsequent to June 30, 2024, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months.

Subsequent to June 30, 2024, the Company executed a revenue generating agreement with RoPower Nuclear S.A. (“RoPower”) in relation to the advancement of Doicesti project Phase 2 Front-End Engineering Design, a project which targets the development of six NuScale power modules at a former coal plant site in Doicești, Romania.
v3.24.2.u1
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation
The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented.

Principles of Consolidation

As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale LLC, a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid assets. All significant intercompany transactions have been eliminated upon consolidation.

Changes in Presentation

For the six months ended June 30, 2023, amounts totaling $1,855 were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.

Cash, Cash Equivalents and Restricted Cash

Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.

Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at June 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows.
Sales and Marketing Agreements

The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of June 30, 2024 and December 31, 2023, the balance of $7,500 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024.

Warrant Liability

The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price.

Sponsored Cost Share

As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities.
As of June 30, 2024, these entities include the United States Department of State and United States Trade and Development Agency (combined as “USG”), RoPower, DOE and CFPP LLC.

Beginning in 2021, the Company partnered with USG to develop SMRs in foreign markets. Under USG’s technical assistance grant programs, we receive cost share commitments to support licensing work in these foreign markets, one of which is additionally supported by RoPower. During the three months ended June 30, 2024 and 2023, USG cost share totaled $2,397 and $6,882, respectively, while during the six months ended June 30, 2024 and 2023, USG cost share totaled $5,192 and $9,297, respectively.

Since 2014, DOE has provided critical funding to the Company through a series of cooperative agreements that support ongoing commercialization activities. Although we did not receive any cost share from DOE during the second quarter, during the six months ended June 30, 2024, DOE cost share totaled $336. During the three and six months ended June 30, 2023, DOE cost share totaled $7,193 and $19,547, respectively.

Finally, we receive subrecipient cost share from CFPP LLC under a contract between the DOE and UAMPS for R&D performed with the goal of developing our first SMR. Under this agreement we received cost share of $51 and $2,165 during the three months ended June 30, 2024 and 2023, respectively, while for the six months ended June 30, 2024 and 2023, the Company received cost share of $316 and $5,104, respectively.

Recent Accounting Pronouncements
Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.
v3.24.2.u1
Noncontrolling Interests and Loss Per Share
6 Months Ended
Jun. 30, 2024
Noncontrolling Interest And Loss Per Share [Abstract]  
Noncontrolling Interests and Loss Per Share Noncontrolling Interests and Loss Per Share
Noncontrolling Interests

Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders.
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
Noncontrolling Interests2024202320242023
NuScale Corp Class A common stock
Beginning of period86,760,24370,061,05576,895,16669,353,019
Exchange of combined interests into Class A common stock8,6602,370,80512,2972,370,805
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period92,486,35874,045,20692,486,35874,045,206
NuScale LLC Class B Units (NCI)
Beginning of period154,473,395157,090,820154,477,032157,090,820
Exchange of combined interests into Class A common stock(8,660)(2,370,805)(12,297)(2,370,805)
End of period154,464,735154,720,015154,464,735154,720,015
Total
Beginning of period241,233,638227,151,875231,372,198226,443,839
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period246,951,093228,765,221246,951,093228,765,221
Ownership Percentage
NuScale Corp Class A common stock
Beginning of period36.0 %30.8 %33.2 %30.6 %
End of period37.5 %32.4 %37.5 %32.4 %
NuScale LLC Class B Units (NCI)
Beginning of period64.0 %69.2 %66.8 %69.4 %
End of period62.5 %67.6 %62.5 %67.6 %
The NCI may decrease according to the number of shares of Class B common stock and NuScale LLC Class B units that are exchanged for shares of Class A common stock or, in certain circumstances including at the election of NuScale Corp, cash in an amount equal to the fair value of Class A common stock received in a contemporaneous equity issuance. After each exchange, NuScale LLC equity attributable to NuScale Corp is rebalanced to reflect the change in ownership percentage, which is calculated above based on Class B units and Class A shares, as a percentage of Combined interests.

Loss Per Share

Basic loss per share is based on the average number of shares of Class A common stock outstanding during the period. Diluted loss per share is based on the average number of shares of Class A common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of RSUs, Stock Options and Warrants using the “treasury stock”
method and for all other interests that convert into potential shares of Class A common stock, if any, using the “if converted” method. Net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the Company’s share of NuScale LLC’s net loss, net of NuScale Corp taxes, after giving effect to all other interests that convert into potential shares of Class A common stock, to the extent it is dilutive. In addition, net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the after-tax impact of changes to the fair value of derivative liabilities, to the extent the Company’s Warrants are dilutive.

The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented.
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
(in thousands, except share and per share amounts)2024202320242023
Net loss attributable to Class A common stockholders$(27,617)$(9,523)$(44,189)$(20,485)
Weighted-average shares for basic and diluted loss per share89,553,679 72,125,375 84,569,371 70,913,646 
Basic and Diluted loss per share of Class A common stock$(0.31)$(0.13)$(0.52)$(0.29)
Anti-dilutive securities excluded from shares outstanding:
    Shares of Class B common stock154,464,735 154,720,015 154,464,735 154,720,015 
    Stock options9,884,004 10,413,895 9,884,004 10,413,895 
    Warrants18,458,701 18,458,701 18,458,701 18,458,701 
    Time-based RSUs5,975,343 3,301,761 5,975,343 3,301,761 
Total188,782,783 186,894,372 188,782,783 186,894,372 

During the three and six months ended June 30, 2024, the Company issued and sold shares of Class A common stock in the amount of 4,198,064 and 12,696,994, respectively, at a weighted average price of $7.58 and $5.87 per share, respectively. During the three months ended June 30, 2024, the ATM Program generated gross and net proceeds of $31,821 and $31,025, respectively, while for the six months ended June 30, 2024 the ATM Program generated gross and net proceeds of $74,502 and $72,639, respectively. As of June 30, 2024, we have 5,565,628 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $65,142.

Subsequent to June 30, 2024, the Company issued and sold 1,420,391 shares of Class A common stock under the ATM Program for the gross and net proceeds of $18,858 and $18,386, respectively.
v3.24.2.u1
Warrant Liabilities
6 Months Ended
Jun. 30, 2024
Warrants and Rights Note Disclosure [Abstract]  
Warrant Liabilities Warrant Liabilities
Under the Company’s Warrant Agreement, when Private Placement Warrants are transferred by Spring Valley Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), to persons who are not “Permitted Transferees” (as defined in the Warrant Agreement) of the Sponsor, they cease to be Private Placement Warrants and become Public Warrants under the Warrant Agreement. The Company has been informed by the Sponsor that the Private Placement Warrants were transferred in accordance with the Warrant Agreement to persons who are not Permitted Transferees. Consequently, the previously described Private Placement Warrants are now Public Warrants under the Warrant Agreement, resulting in all 18,458,701 warrants identified as Public Warrants in Note 5, Fair Value Measurement, as of June 30, 2024.
Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants are currently exercisable and will expire on May 2, 2027 (five years from the date of the Transaction) or earlier upon redemption or liquidation.

Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00. The Company may redeem the outstanding Warrants:
in whole and not in part;
at a price of $0.01 per Warrant;
upon a minimum of 30 days prior written notice of redemption to each Warrant holder; and
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.

The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00. The Company may redeem the outstanding Warrants:
in whole and not in part;
at $0.10 per Warrant upon a minimum of 30 days prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined as set forth in the Warrant Agreement, based on the redemption date and the fair market value of the Class A common stock, subject to certain exceptions; and
if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant based on anti-dilution adjustments set forth in the Warrant Agreement) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.

The Warrants may be exercised for cash (or on a cashless basis as described above in “-Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00”) at any time after notice of redemption shall have been given by the Company and prior to the redemption date.

For a complete description of the Warrants, please see the Warrant Agreement, which is Exhibit 4.2 to the 2023 Form 10-K, and the section entitled “Warrants” in the “Description of Registrant’s Securities,” which is Exhibit 4.3 to the 2023 Form 10-K.
v3.24.2.u1
Fair Value Measurement
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach).
The levels of hierarchy are described below:
Level 1 Quoted prices in active markets for identical instruments;
Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement.
The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities.

Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities, because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of June 30, 2024.

The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis:
(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities: 
   Public Warrants$51,500 $— $— $51,500 
Total Warrant Liabilities as of June 30, 2024$51,500 $— $— $51,500 

(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities:
   Public Warrants$2,963 $— $— $2,963 
   Private Placement Warrants— 2,759 — 2,759 
Total Warrant Liabilities as of December 31, 2023$2,963 $2,759 $— $5,722 
v3.24.2.u1
Accounts and Other Receivables
6 Months Ended
Jun. 30, 2024
Receivables [Abstract]  
Accounts and Other Receivables Accounts and Other Receivables
Accounts and other receivables include reimbursement requests outstanding from the cost share awards, interest receivable and commercial accounts receivable. The cost share reimbursement requests are recognized as eligible costs are incurred. Reimbursement under the awards is recognized as award funds are obligated, and are included in Sponsored cost share in the condensed consolidated statement of operations. Interest receivable of $431 and $318 was outstanding at June 30, 2024 and December 31, 2023, respectively.

The majority of our receivables are either due from the U.S. federal government or have to do with a federal project. For these reasons, all receivables are deemed to be fully collectible and no allowance has been recorded.
v3.24.2.u1
Property, Plant and Equipment
6 Months Ended
Jun. 30, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Property, Plant and Equipment
Property, plant and equipment consisted of the following:
(in thousands)
June 30, 2024December 31, 2023
Furniture and fixtures$27 $27 
Office and computer equipment7,222 7,274 
Software13,898 14,102 
Operations equipment1,165 1,165 
Leasehold improvements2,189 2,293 
24,501 24,861 
Less: Accumulated depreciation(21,351)(20,745)
Net property, plant and equipment$3,150 $4,116 
Depreciation of property, plant and equipment for the three months ended June 30, 2024 and 2023 was $402 and $556, respectively. Of these amounts, $80 and $322 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $137 and $419, respectively, for the 2023 fiscal year.
Depreciation of property, plant and equipment for the six months ended June 30, 2024 and 2023 was $892 and $1,172, respectively. Of these amounts, $174 and $718 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $277 and $895, respectively, for the 2023 fiscal year.
v3.24.2.u1
Long-Lead Material Work In Process and Liability
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Long-Lead Material Work In Process and Liability Long-Lead Material Work In Process and Liability
During the first quarter of 2023, we entered into the LLM Agreement with CFPP LLC. Related to this contract, the Company has subcontracted for the purchase of certain long-lead materials (“LLM”) in the amount of $55,700, that were to be used in fabrication of the NPMs as part of the DCRA with CFPP LLC. However, on November 7, 2023, NuScale and CFPP LLC entered into the Release Agreement whereby the DCRA and LLM Agreement would be suspended, while wind down procedures and the ultimate disposition of the long-lead materials would be negotiated between the Company, CFPP LLC and DOE. As part of the Release Agreement, NuScale was required to pay $49,769 to CFPP LLC and provide a letter of credit in the amount of $5,000 for demobilization and wind down costs. This letter of credit is collateralized by $5,100 and included in the accompanying condensed consolidated balance sheet as Restricted cash as of June 30, 2024 and December 31, 2023.
Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations of the LLM. As a result of DOE’s investment in the LLM, as of June 30, 2024 and December 31, 2023, NuScale has included a Long-lead material liability on the accompanying condensed consolidated balance sheet in the amount of $32,445, for the estimated cost to gain 100% of the LLM, once completed. The LLM represents in process inventory recorded at cost and is identified as Long-lead material work in process on the condensed consolidated balance sheet in the amount of $41,227 and $36,361 as of June 30, 2024 and December 31, 2023, respectively.
v3.24.2.u1
Noncurrent Accounts Payable and Accrued Expenses
6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
Noncurrent Accounts Payable and Accrued Expenses Noncurrent Accounts Payable and Accrued ExpensesDuring the three months ended June 30, 2024, a contract with one of NuScale’s LLM manufacturing vendors was renegotiated as a result of the Release Agreement with CFPP LLC. This amendment resulted in new production milestones, with interest-free payments expected between July 2025 and December 2025. Should the payments be deferred to a later date, interest will begin accruing on January 1, 2026. As a result, we have reclassified $24,880 out of Accounts payable and accrued expenses into Noncurrent accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet.
v3.24.2.u1
Employee Benefits
6 Months Ended
Jun. 30, 2024
Retirement Benefits [Abstract]  
Employee Benefits Employee BenefitsThe Company sponsors a defined contribution 401(k) Plan with contributions to be made at the sole discretion of the management. Under the provisions of the 401(k) Plan, the Company matches the employees’ contributions for the first 3% of compensation and matches 50% of the employees’ contributions for the next 2% of compensation. The expense recorded for the 401(k) Plan was $526 and $691 for the three months ended June 30, 2024 and 2023, respectively, and $1,139 and $1,442 for the six months ended June 30, 2024 and 2023, respectively
v3.24.2.u1
Income Taxes
6 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
NuScale LLC was historically and remains a partnership for U.S. federal income tax purposes with each partner being separately taxed on its share of taxable income or loss. NuScale Corp is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of any net taxable income or loss and any related tax credits of NuScale LLC.

The effective tax rate was 0% for the three and six months ended June 30, 2024. The effective income tax rate for the three and six months ended June 30, 2024 differed significantly from the statutory rates, primarily due to the losses allocated to NCI and the recognition of a valuation allowance as a result of the Company’s new tax structure following the Transaction.

There was no income tax expense recorded during the three and six months ended June 30, 2024.

The Company has assessed the realizability of the net deferred tax assets and in that analysis has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets at NuScale Corp as of June 30, 2024, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.

The Company’s income tax filings will be subject to audit by various taxing jurisdictions. The Company will monitor the status of U.S. federal, state and local income tax returns that may be subject to audit in future periods. No U.S. federal, state and local income tax returns are currently under examination by the respective taxing authorities.
v3.24.2.u1
Equity-Based Compensation
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation Equity-Based Compensation
The total compensation expense recognized for common share options and time-based RSU awards during the three months ended June 30, 2024 and 2023 was $4,277 and $4,453, respectively, and $6,496 and $8,090 for the six months ended June 30, 2024 and 2023, respectively. For the three months ended June 30, 2024, equity-based compensation of $1,981 was included in G&A expense and $2,296 was included in Other expense, compared to $1,868 and $2,585, respectively, over the same periods in the prior year. For the six months ended June 30, 2024, equity based compensation of $3,428 was included in G&A expense and $3,068 included in Other expense compared to $3,361 and $4,729, respectively, over the same periods in the prior year.

Stock Options

During the six months ended June 30, 2024, the Board approved 2,909,375 employee share option awards, with an aggregate fair value of $6,401, that vest one-third annually starting in February 2025 for a period of three years.

The Company measures the fair value of each share option grant at the date of grant using a Black-Scholes option pricing model.

Time-based RSUs
During the six months ended June 30, 2024, the Company granted employees 4,598,635 RSUs with an aggregate value of $14,716. The RSUs vest one-third annually starting in February 2025. During the three and six months ended June 30, 2024, RSUs totaling 450,332 and 918,239, respectively, vested and the Class A shares were issued.
v3.24.2.u1
Related Party Transactions
6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
From time to time, the Company enters into strategic agreements with Fluor, whereby Fluor or the Company perform services for one another. For the three months ended June 30, 2024 and 2023, we incurred expenses of $291 and $8,479, respectively, while for the six months ended June 30, 2024 and 2023, we incurred expenses of $538 and $17,205, respectively. As of June 30, 2024 and December 31, 2023, the Company owed Fluor, as Accounts payable and accrued expenses on the condensed consolidated balance sheet, amounts totaling $1,233 and $4,080, respectively. For the three months ended June 30, 2024 and 2023, we earned revenue of $523 and $4,756, respectively, and for the six months ended June 30, 2024 and 2023, we earned $523 and $8,770, respectively. As of June 30, 2024 and December 31, 2023, Fluor owed us $523 and $2,642, respectively, amounts which are included in Accounts and other receivables on the condensed consolidated balance sheet.

For the three months ended June 30, 2024 and 2023, Fluor accounted for 54% and 82%, respectively, of total revenue, while for the six months ended June 30, 2024 and 2023, they accounted for 22% and 78%, respectively.
v3.24.2.u1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations.

On September 19, 2022, thirteen purported members of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with the Merger between NuScale LLC and Spring Valley Acquisition Corp. NuScale LLC filed a motion to dismiss the complaint on November 21, 2022. Plaintiffs filed a response on January 17, 2023, and NuScale LLC filed a reply on February 14, 2023. A hearing on various motions to dismiss took place on May 17, 2023, and on August 3, 2023, the Magistrate Judge assigned to the case issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to the report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, Plaintiffs filed a motion for leave to amend their complaint, seeking to add claims and bring back defendants that were dismissed from the complaint at an earlier stage of the litigation (Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC). NuScale LLC and the other defendants opposed the proposed amendment. On May 2, 2024, the Magistrate Judge issued a report and recommendation that recommended that Plaintiffs’ proposed amendment be denied. Plaintiffs did not file an objection to this report, and it was adopted by the District Court Judge on June 24, 2024. That same day, the Court ordered that the parties confer and provide proposed dates for completing discovery and filing any dispositive motions. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.

Two other shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company, John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court has appointed lead plaintiff and lead counsel, and they filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants’ filed a
motion to dismiss on June 17, 2024. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.
In connection with DOE and UAMPS Award 8935, DOE designated NuScale as a subrecipient to UAMPS for the production of NPM 1, while classifying NuScale as a contractor or subcontractor for NPMs 2-6. As part of DOE’s classification of NuScale as a contractor or subcontractor for NPMs 2-6, DOE noted that should NuScale fail to initiate commercial operation of NPM 1, DOE has the right to demand repayment of the fees invoiced for NPMs 2-6.
v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (27,617) $ (9,523) $ (44,189) $ (20,485)
v3.24.2.u1
Insider Trading Arrangements
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Trading Arrangements, by Individual    
Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
José Reyes Jr. [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the three months ended June 30, 2024, one officer of the Company, José Reyes Jr., terminated his 10b5-1 plan on April 23, 2024.
Name José Reyes Jr.  
Title officer  
Rule 10b5-1 Arrangement Terminated true  
Termination Date April 23, 2024  
v3.24.2.u1
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented.
Principles of Consolidation
Principles of Consolidation
As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale LLC, a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid assets. All significant intercompany transactions have been eliminated upon consolidation.
Changes in Presentation
Changes in Presentation
For the six months ended June 30, 2023, amounts totaling $1,855 were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash

Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.

Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at June 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows.
Sales and Marketing Agreements
Sales and Marketing Agreements

The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of June 30, 2024 and December 31, 2023, the balance of $7,500 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024.
Warrant Liability
Warrant Liability
The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price.
Sponsored Cost Share
Sponsored Cost Share

As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities.
As of June 30, 2024, these entities include the United States Department of State and United States Trade and Development Agency (combined as “USG”), RoPower, DOE and CFPP LLC.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Management believes there is no new accounting guidance issued but not yet effective that would have a material impact to the Company’s current financial statements.
Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach).
The levels of hierarchy are described below:
Level 1 Quoted prices in active markets for identical instruments;
Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement.
The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities.

Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities, because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of June 30, 2024.
v3.24.2.u1
Noncontrolling Interests and Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2024
Noncontrolling Interest And Loss Per Share [Abstract]  
Schedule of Non-Controlling Interests
Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders.
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
Noncontrolling Interests2024202320242023
NuScale Corp Class A common stock
Beginning of period86,760,24370,061,05576,895,16669,353,019
Exchange of combined interests into Class A common stock8,6602,370,80512,2972,370,805
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period92,486,35874,045,20692,486,35874,045,206
NuScale LLC Class B Units (NCI)
Beginning of period154,473,395157,090,820154,477,032157,090,820
Exchange of combined interests into Class A common stock(8,660)(2,370,805)(12,297)(2,370,805)
End of period154,464,735154,720,015154,464,735154,720,015
Total
Beginning of period241,233,638227,151,875231,372,198226,443,839
Issuance of Class A common stock4,198,06412,696,994
Exercise of options, warrants and vested RSUs1,519,3911,613,3462,881,9012,321,382
End of period246,951,093228,765,221246,951,093228,765,221
Ownership Percentage
NuScale Corp Class A common stock
Beginning of period36.0 %30.8 %33.2 %30.6 %
End of period37.5 %32.4 %37.5 %32.4 %
NuScale LLC Class B Units (NCI)
Beginning of period64.0 %69.2 %66.8 %69.4 %
End of period62.5 %67.6 %62.5 %67.6 %
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented.
As of and for the Three Months Ended June 30,As of and for the Six Months Ended June 30,
(in thousands, except share and per share amounts)2024202320242023
Net loss attributable to Class A common stockholders$(27,617)$(9,523)$(44,189)$(20,485)
Weighted-average shares for basic and diluted loss per share89,553,679 72,125,375 84,569,371 70,913,646 
Basic and Diluted loss per share of Class A common stock$(0.31)$(0.13)$(0.52)$(0.29)
Anti-dilutive securities excluded from shares outstanding:
    Shares of Class B common stock154,464,735 154,720,015 154,464,735 154,720,015 
    Stock options9,884,004 10,413,895 9,884,004 10,413,895 
    Warrants18,458,701 18,458,701 18,458,701 18,458,701 
    Time-based RSUs5,975,343 3,301,761 5,975,343 3,301,761 
Total188,782,783 186,894,372 188,782,783 186,894,372 
v3.24.2.u1
Fair Value Measurement (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Liabilities Measured on Recurring Basis
The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis:
(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities: 
   Public Warrants$51,500 $— $— $51,500 
Total Warrant Liabilities as of June 30, 2024$51,500 $— $— $51,500 

(in thousands)Level 1Level 2Level 3Total
Warrant Liabilities:
   Public Warrants$2,963 $— $— $2,963 
   Private Placement Warrants— 2,759 — 2,759 
Total Warrant Liabilities as of December 31, 2023$2,963 $2,759 $— $5,722 
v3.24.2.u1
Property, Plant and Equipment (Tables)
6 Months Ended
Jun. 30, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Property, plant and equipment consisted of the following:
(in thousands)
June 30, 2024December 31, 2023
Furniture and fixtures$27 $27 
Office and computer equipment7,222 7,274 
Software13,898 14,102 
Operations equipment1,165 1,165 
Leasehold improvements2,189 2,293 
24,501 24,861 
Less: Accumulated depreciation(21,351)(20,745)
Net property, plant and equipment$3,150 $4,116 
v3.24.2.u1
Nature of Business (Details)
$ in Thousands
Jan. 05, 2024
employee
Jun. 30, 2024
USD ($)
MW
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Number of megawatts (mw) | MW   77
Number of positions eliminated | employee 154  
Transition percentage 28.00%  
Restructuring charges | $   $ 3,236
v3.24.2.u1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Other expenses $ (13,036) $ (12,896) $ (25,139) $ (28,192)  
Research and development expenses 12,132 26,932 25,287 54,502  
Restricted cash 5,100   5,100   $ 5,100
Prepaid and other assets noncurrent portion 7,500   7,500   $ 15,000
United State Trade and Development Agency | Government          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Collaborative arrangement, cost share 2,397 6,882 5,192 9,297  
Nuscale SMR FOAK Nuclear Demonstration Readiness Project Completion          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Collaborative arrangement, cost share 0 7,193 336 19,547  
CFPP LLC | Government          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Collaborative arrangement, government cost share $ 51 $ 2,165 $ 316 5,104  
Revision of Prior Period, Reclassification, Adjustment          
Accounts, Notes, Loans and Financing Receivable [Line Items]          
Other expenses       1,855  
Research and development expenses       $ 1,855  
v3.24.2.u1
Noncontrolling Interests and Loss Per Share - Schedule of Non-Controlling Interests (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Noncontrolling Interest [Roll Forward]        
Beginning of period (shares) 241,233,638 227,151,875 231,372,198 226,443,839
Issuance of Class A common stock (shares) 4,198,064 0 12,696,994 0
Exercise of options and warrants and vested RSUs (shares) 1,519,391 1,613,346 2,881,901 2,321,382
End of period (shares) 246,951,093 228,765,221 246,951,093 228,765,221
Class A        
Noncontrolling Interest [Roll Forward]        
Beginning of period (shares) 86,760,243 70,061,055 76,895,166 69,353,019
Exchange of combined interests into Class A common stock (shares) 8,660 2,370,805 12,297 2,370,805
Issuance of Class A common stock (shares) 4,198,064 0 12,696,994 0
Exercise of options and warrants and vested RSUs (shares) 1,519,391 1,613,346 2,881,901 2,321,382
End of period (shares) 92,486,358 74,045,206 92,486,358 74,045,206
Class A | NuScale Corp        
Controlling and Non Controlling Interest [Roll Forward]        
Beginning of period 36.00% 30.80% 33.20% 30.60%
End of period 37.50% 32.40% 37.50% 32.40%
Class B        
Noncontrolling Interest [Roll Forward]        
Beginning of period (shares) 154,473,395 157,090,820 154,477,032 157,090,820
Exchange of combined interests into Class A common stock (shares) (8,660) (2,370,805) (12,297) (2,370,805)
End of period (shares) 154,464,735 154,720,015 154,464,735 154,720,015
Class B | NuScale LLC        
Controlling and Non Controlling Interest [Roll Forward]        
Beginning of period 64.00% 69.20% 66.80% 69.40%
End of period 62.50% 67.60% 62.50% 67.60%
v3.24.2.u1
Noncontrolling Interests and Loss Per Share - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 08, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
shares
Class B        
Noncontrolling Interest [Line Items]        
Common stock, votes per share   1 1  
Common stock, shares authorized (shares) | shares   179,000,000 179,000,000 179,000,000
Class A        
Noncontrolling Interest [Line Items]        
Common stock, shares authorized (shares) | shares   332,000,000 332,000,000 332,000,000
Class A | ATM Program        
Noncontrolling Interest [Line Items]        
Sale of stock, number of shares issued in transaction (shares) | shares   4,198,064 12,696,994  
Sale of stock, price per share (in dollars per share) | $ / shares   $ 7.58 $ 5.87  
Proceeds from issuance of common stock gross | $   $ 31,821 $ 74,502  
Proceeds from the issuance of common stock, net of issuance fees | $   $ 31,025 $ 72,639  
Common stock, shares authorized (shares) | shares   5,565,628 5,565,628  
Sale of stock, consideration received per transaction | $     $ 65,142  
Class A | ATM Program | Subsequent Event        
Noncontrolling Interest [Line Items]        
Sale of stock, number of shares issued in transaction (shares) | shares 1,420,391      
Proceeds from issuance of common stock gross | $ $ 18,858      
Proceeds from the issuance of common stock, net of issuance fees | $ $ 18,386      
v3.24.2.u1
Noncontrolling Interests and Loss Per Share - Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Noncontrolling Interest And Loss Per Share [Abstract]        
Net loss attributable to Class A common stockholders, basic $ (27,617) $ (9,523) $ (44,189) $ (20,485)
Net loss attributable to Class A common stockholders, diluted $ (27,617) $ (9,523) $ (44,189) $ (20,485)
Weighted-average shares for basic loss per share (shares) 89,553,679 72,125,375 84,569,371 70,913,646
Weighted-average shares for diluted loss per share (shares) 89,553,679 72,125,375 84,569,371 70,913,646
Basic loss per share of Class A common stock (usd per share) $ (0.31) $ (0.13) $ (0.52) $ (0.29)
Diluted loss per share of Class A common stock (usd per share) $ (0.31) $ (0.13) $ (0.52) $ (0.29)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities excluded (shares) 188,782,783 186,894,372 188,782,783 186,894,372
Shares of Class B common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities excluded (shares) 154,464,735 154,720,015 154,464,735 154,720,015
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities excluded (shares) 9,884,004 10,413,895 9,884,004 10,413,895
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities excluded (shares) 18,458,701 18,458,701 18,458,701 18,458,701
Time-based RSUs        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities excluded (shares) 5,975,343 3,301,761 5,975,343 3,301,761
v3.24.2.u1
Warrant Liabilities (Details)
6 Months Ended
Jun. 30, 2024
day
$ / shares
shares
Derivative [Line Items]  
Warrants and rights outstanding, term 5 years
Warrant Redemption Scenario One  
Derivative [Line Items]  
Stock price trigger (usd per share) | $ / shares $ 18.00
Redemption price (usd per share) | $ / shares $ 0.01
Prior written notice period for redemption 30 days
Threshold trading days 20
Threshold consecutive trading day period 30
Redemption period 30
Warrant Redemption Scenario Two  
Derivative [Line Items]  
Stock price trigger (usd per share) | $ / shares $ 10.00
Redemption price (usd per share) | $ / shares $ 0.10
Prior written notice period for redemption 30 days
Threshold trading days 20
Threshold consecutive trading day period 30
Public Warrants  
Derivative [Line Items]  
Class of warrant outstanding (shares) | shares 18,458,701
v3.24.2.u1
Fair Value Measurement (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities $ 51,500 $ 5,722
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 51,500 5,722
Fair Value, Recurring | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 51,500 2,963
Fair Value, Recurring | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities   2,759
Level 1 | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 51,500 2,963
Level 1 | Fair Value, Recurring | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 51,500 2,963
Level 1 | Fair Value, Recurring | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities   0
Level 2 | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 2,759
Level 2 | Fair Value, Recurring | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 0
Level 2 | Fair Value, Recurring | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities   2,759
Level 3 | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 0
Level 3 | Fair Value, Recurring | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities $ 0 0
Level 3 | Fair Value, Recurring | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities   $ 0
v3.24.2.u1
Accounts and Other Receivables (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Receivables [Abstract]    
DOE cost share liabilities $ 431 $ 318
v3.24.2.u1
Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Less: Accumulated depreciation $ (21,351) $ (20,745)
Net property, plant and equipment 3,150 4,116
Depreciable Property, Plant And Equipment    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross 24,501 24,861
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross 27 27
Office and computer equipment    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross 7,222 7,274
Software    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross 13,898 14,102
Operations equipment    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross 1,165 1,165
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment gross $ 2,189 $ 2,293
v3.24.2.u1
Property, Plant and Equipment - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Property, Plant and Equipment [Line Items]        
Depreciation $ 402 $ 556 $ 892 $ 1,172
General and Administrative Expense        
Property, Plant and Equipment [Line Items]        
Depreciation 80 137 174 277
Other Expense        
Property, Plant and Equipment [Line Items]        
Depreciation $ 322 $ 419 $ 718 $ 895
v3.24.2.u1
Long-Lead Material Work In Process and Liability (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Nov. 07, 2023
Mar. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Purchase of certain long-lead materials $ 32,445 $ 32,323    
Restricted cash 5,100 5,100    
Long-lead material work in process 41,227 36,361    
CFPP LLC | Long Lead Material Contract        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Purchase of certain long-lead materials $ 32,445 $ 32,445   $ 55,700
Settlement and release agreement, initial payment, agreed amount     $ 49,769  
Letters of credit     $ 5  
Estimated cost percentage 100.00% 100.00%    
Long-lead material work in process $ 41,227 $ 36,361    
v3.24.2.u1
Noncurrent Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Reclassification [Line Items]    
Accounts payable and accrued expenses $ (19,098) $ (44,925)
Noncurrent accounts payable and accrued expenses 24,880 $ 0
Reclassification, Other    
Reclassification [Line Items]    
Accounts payable and accrued expenses 24,880  
Noncurrent accounts payable and accrued expenses $ 24,880  
v3.24.2.u1
Employee Benefits (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Defined Contribution Plan Disclosure [Line Items]        
Defined contribution plan expense $ 526 $ 691 $ 1,139 $ 1,442
Defined Contribution Plan, Tranche One        
Defined Contribution Plan Disclosure [Line Items]        
Defined contribution plan, employer matching contribution, percent of employees' gross pay     3.00%  
Defined contribution plan, employer matching contribution, percent of match     100.00%  
Defined Contribution Plan, Tranche Two        
Defined Contribution Plan Disclosure [Line Items]        
Defined contribution plan, employer matching contribution, percent of employees' gross pay     2.00%  
Defined contribution plan, employer matching contribution, percent of match     50.00%  
v3.24.2.u1
Income Taxes (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Tax Disclosure [Abstract]        
Effective income tax rate, percent 0.00%   0.00%  
Provision (benefit) for income taxes $ 0 $ 0 $ 0 $ 0
v3.24.2.u1
Equity-Based Compensation - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share-Based Payment Arrangement, Option        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share based compensation expense $ 4,277 $ 4,453 $ 6,496 $ 8,090
Granted (shares) 2,909,375   2,909,375  
Shares approved, value $ 6,401   $ 6,401  
Award vesting period (in years)     3 years  
Vesting percentage     33.33%  
Share-Based Payment Arrangement, Option | General and Administrative Expense        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share based compensation expense 1,981 1,868 $ 3,428 3,361
Share-Based Payment Arrangement, Option | Other Expense        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share based compensation expense $ 2,296 $ 2,585 $ 3,068 $ 4,729
Time-based RSUs        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Granted (shares) 4,598,635   4,598,635  
Vested in period, fair value     $ 14,716  
Vested (shares) 450,332   918,239  
Vesting percentage     33.33%  
v3.24.2.u1
Related Party Transactions (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Related Party Transaction [Line Items]          
Revenue $ 967 $ 5,795 $ 2,346 $ 11,300  
Related Party          
Related Party Transaction [Line Items]          
Accounts payable 1,233   1,233   $ 4,080
Revenue 523 $ 4,756 523 $ 8,770  
Accounts and other receivables $ 523   $ 523   $ 2,642
Related Party | Fluor          
Related Party Transaction [Line Items]          
Percentage of revenue earned 54.00% 82.00% 22.00% 78.00%  
Services Performed          
Related Party Transaction [Line Items]          
Related party transaction, amounts of transaction $ 291 $ 8,479 $ 538 $ 17,205  
v3.24.2.u1
Commitment and Contingencies (Details)
1 Months Ended
Sep. 19, 2022
plaintiff
Dec. 26, 2023
lawsuit
Commitments and Contingencies Disclosure [Abstract]    
Number of plaintiffs | plaintiff 13  
Number of additional lawsuits | lawsuit   2

NuScale Power (NYSE:SMR)
Historical Stock Chart
From Oct 2024 to Oct 2024 Click Here for more NuScale Power Charts.
NuScale Power (NYSE:SMR)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more NuScale Power Charts.